Coupling	O
of	O
a	O
signal	B-protein
response	I-protein
domain	I-protein
in	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
to	O
multiple	O
pathways	O
for	O
NF-kappa	B-protein
B	I-protein
activation	O
.	O

The	O
eukaryotic	B-protein
transcription	I-protein
factor	I-protein
NF-kappa	B-protein
B	I-protein
plays	O
a	O
central	O
role	O
in	O
the	O
induced	O
expression	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
and	O
in	O
many	O
aspects	O
of	O
the	O
genetic	O
program	O
mediating	O
normal	O
T-cell	O
activation	O
and	O
growth	O
.	O

The	O
nuclear	O
activity	O
of	O
NF-kappa	B-protein
B	I-protein
is	O
tightly	O
regulated	O
from	O
the	O
cytoplasmic	O
compartment	O
by	O
an	O
inhibitory	B-protein
subunit	I-protein
called	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

This	O
cytoplasmic	O
inhibitor	O
is	O
rapidly	O
phosphorylated	O
and	O
degraded	O
in	O
response	O
to	O
a	O
diverse	O
set	O
of	O
NF-kappa	B-protein
B-inducing	I-protein
agents	I-protein
,	O
including	O
T-cell	B-protein
mitogens	I-protein
,	I-protein
proinflammatory	B-protein
cytokines	I-protein
,	O
and	O
viral	B-protein
transactivators	I-protein
such	O
as	O
the	O
Tax	B-protein
protein	I-protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
.	O

To	O
explore	O
these	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
-dependent	O
mechanisms	O
for	O
NF-kappa	B-protein
B	I-protein
induction	O
,	O
we	O
identified	O
novel	O
mutants	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
that	O
uncouple	O
its	O
inhibitory	O
and	O
signal-transducing	O
functions	O
in	O
human	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

Specifically	O
,	O
removal	O
of	O
the	O
N-terminal	B-protein
36	I-protein
amino	I-protein
acids	I-protein
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
failed	O
to	O
disrupt	O
its	O
ability	O
to	O
form	O
latent	O
complexes	O
with	O
NF-kappa	B-protein
B	I-protein
in	O
the	O
cytoplasm	O
.	O

However	O
,	O
this	O
deletion	O
mutation	O
prevented	O
the	O
induced	O
phosphorylation	O
,	O
degradative	O
loss	O
,	O
and	O
functional	O
release	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
from	O
NF-kappa	B-protein
B	I-protein
in	O
Tax-expressing	B-cell_line
cells	I-cell_line
.	O

Alanine	O
substitutions	O
introduced	O
at	O
two	O
serine	O
residues	O
positioned	O
within	O
this	O
N-terminal	B-protein
regulatory	I-protein
region	I-protein
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
also	O
yielded	O
constitutive	O
repressors	O
that	O
escaped	O
from	O
Tax	B-protein
-induced	O
turnover	O
and	O
that	O
potently	O
inhibited	O
immune	O
activation	O
pathways	O
for	O
NF-kappa	B-protein
B	I-protein
induction	O
,	O
including	O
those	O
initiated	O
from	O
antigen	B-protein
and	I-protein
cytokine	I-protein
receptors	I-protein
.	O

In	O
contrast	O
,	O
introduction	O
of	O
a	O
phosphoserine	O
mimetic	O
at	O
these	O
sites	O
rectified	O
this	O
functional	O
defect	O
,	O
a	O
finding	O
consistent	O
with	O
a	O
causal	O
linkage	O
between	O
the	O
phosphorylation	O
status	O
and	O
proteolytic	O
stability	O
of	O
this	O
cytoplasmic	B-protein
inhibitor	I-protein
.	O

Together	O
,	O
these	O
in	O
vivo	O
studies	O
define	O
a	O
critical	O
signal	O
response	O
domain	O
in	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
that	O
coordinately	O
controls	O
the	O
biologic	O
activities	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
and	O
NF-kappa	B-protein
B	I-protein
in	O
response	O
to	O
viral	O
and	O
immune	O
stimuli	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGY	NULL
,	NULL
May	NULL
1995	NULL
,	NULL
p.	NULL
2809-2818	NULL
0270-7306/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Coupling	NULL
of	NULL
a	NULL
Signal	NULL
Response	NULL
Domain	NULL
in	NULL
IxBa	NULL
to	NULL
Multiple	NULL
Pathways	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
JEFFREY	NULL
A.	NULL
BROCKMAN	NULL
,	NULL
DAVID	NULL
C.	NULL
SCHERER	NULL
,	NULL
TIMOTHY	NULL
A.	NULL
McKINSEY	NULL
,	NULL
SARAH	NULL
M.	NULL
HALL	NULL
,	NULL
XIAOXIA	NULL
QI	NULL
,	NULL
WHA	NULL
YOUNG	NULL
LEE	NULL
,	NULL
anp	NULL
DEAN	NULL
W.	NULL
BALLARD*	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nashville	NULL
,	NULL
Tennessee	NULL
Received	NULL
7	NULL
November	NULL
1994/Returned	NULL
for	NULL
modification	NULL
25	NULL
January	NULL
1995/Accepted	NULL
13	NULL
February	NULL
1995	NULL
The	NULL
eukaryotic	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
in	NULL
many	NULL
aspects	NULL
of	NULL
the	NULL
genetic	NULL
program	NULL
mediating	NULL
normal	NULL
T-cell	NULL
activation	NULL
and	NULL
growth	NULL
.	NULL

The	NULL
nuclear	NULL
activity	NULL
of	NULL
NF-KB	NULL
is	NULL
tightly	NULL
regulated	NULL
from	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
by	NULL
an	NULL
inhibitory	NULL
subunit	NULL
called	NULL
IxBa	NULL
.	NULL

This	NULL
cytoplasmic	NULL
inhibitor	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
a	NULL
diverse	NULL
set	NULL
of	NULL
NF-	NULL
agents	NULL
,	NULL
including	NULL
T-cell	NULL
mitogens	NULL
,	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
and	NULL
viral	NULL
trans-activators	NULL
such	NULL
as	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

To	NULL
explore	NULL
these	NULL
IBa-dependent	NULL
mechanisms	NULL
for	NULL
NF-KB	NULL
induction	NULL
,	NULL
we	NULL
identified	NULL
novel	NULL
mutants	NULL
of	NULL
IxBa	NULL
that	NULL
uncouple	NULL
its	NULL
inhibitory	NULL
and	NULL
signal-transducing	NULL
functions	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Specifically	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
N-terminal	NULL
36	NULL
amino	NULL
acids	NULL
of	NULL
IxBa	NULL
failed	NULL
to	NULL
disrupt	NULL
its	NULL
ability	NULL
to	NULL
form	NULL
latent	NULL
complexes	NULL
with	NULL
NF-B	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

However	NULL
,	NULL
this	NULL
deletion	NULL
mutation	NULL
prevented	NULL
the	NULL
induced	NULL
phosphorylation	NULL
,	NULL
degradative	NULL
loss	NULL
,	NULL
and	NULL
functional	NULL
release	NULL
of	NULL
IxBa	NULL
from	NULL
NF-KB	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
.	NULL

Alanine	NULL
substitutions	NULL
introduced	NULL
at	NULL
two	NULL
serine	NULL
residues	NULL
positioned	NULL
within	NULL
this	NULL
N-terminal	NULL
regulatory	NULL
region	NULL
of	NULL
IxBa	NULL
also	NULL
yielded	NULL
constitutive	NULL
repressors	NULL
that	NULL
escaped	NULL
from	NULL
Tax-induced	NULL
turnover	NULL
and	NULL
that	NULL
potently	NULL
inhibited	NULL
immune	NULL
activation	NULL
pathways	NULL
for	NULL
NF-KB	NULL
induction	NULL
,	NULL
including	NULL
those	NULL
initiated	NULL
from	NULL
antigen	NULL
and	NULL
cytokine	NULL
receptors	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
introduction	NULL
of	NULL
a	NULL
phosphoserine	NULL
mimetic	NULL
at	NULL
these	NULL
sites	NULL
rectified	NULL
this	NULL
functional	NULL
defect	NULL
,	NULL
a	NULL
finding	NULL
consistent	NULL
with	NULL
a	NULL
causal	NULL
linkage	NULL
between	NULL
the	NULL
phosphorylation	NULL
status	NULL
and	NULL
proteolytic	NULL
stability	NULL
of	NULL
this	NULL
cytoplasmic	NULL
inhibitor	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
in	NULL
vivo	NULL
studies	NULL
define	NULL
a	NULL
critical	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IxBa	NULL
that	NULL
coordinately	NULL
controls	NULL
the	NULL
biologic	NULL
activities	NULL
of	NULL
IxBa	NULL
and	NULL
NF-KB	NULL
in	NULL
response	NULL
to	NULL
viral	NULL
and	NULL
immune	NULL
stimuli	NULL
.	NULL

The	NULL
eukaryotic	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
participates	NULL
in	NULL
the	NULL
activation	NULL
and	NULL
controlled	NULL
proliferation	NULL
of	NULL
T	NULL
lymphocytes	NULL
during	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
references	NULL
31	NULL
,	NULL
32	NULL
,	NULL
and	NULL
46	NULL
)	NULL
.	NULL

The	NULL
prototypical	NULL
form	NULL
of	NULL
NF-kB	NULL
is	NULL
a	NULL
heterodimeric	NULL
complex	NULL
containing	NULL
two	NULL
DNA	NULL
binding	NULL
sub-units	NULL
,	NULL
termed	NULL
p50	NULL
and	NULL
RelA	NULL
,	NULL
both	NULL
of	NULL
which	NULL
belong	NULL
to	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
5	NULL
,	NULL
16	NULL
,	NULL
28	NULL
,	NULL
43	NULL
,	NULL
54	NULL
,	NULL
60	NULL
,	NULL
67	NULL
)	NULL
.	NULL

When	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
this	NULL
inducible	NULL
complex	NULL
stimulates	NULL
gene	NULL
transcription	NULL
via	NULL
a	NULL
potent	NULL
transactivation	NULL
domain	NULL
in	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
RelA	NULL
(	NULL
7	NULL
,	NULL
68	NULL
,	NULL
70	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
prevented	NULL
because	NULL
of	NULL
high-affinity	NULL
association	NULL
of	NULL
its	NULL
RelA	NULL
subunit	NULL
with	NULL
a	NULL
labile	NULL
cytoplasmic	NULL
inhibitor	NULL
called	NULL
(	NULL
3-5	NULL
,	NULL
11	NULL
,	NULL
27	NULL
)	NULL
.	NULL

This	NULL
IxBa-dependent	NULL
mechanism	NULL
for	NULL
the	NULL
cytoplasmic	NULL
retention	NULL
of	NULL
NF-kB	NULL
is	NULL
uncoupled	NULL
by	NULL
many	NULL
extracellular	NULL
signals	NULL
,	NULL
including	NULL
T-cell	NULL
receptor	NULL
ligands	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
,	NULL
and	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
32	NULL
)	NULL
.	NULL

During	NULL
normal	NULL
T-cell	NULL
activation	NULL
,	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
preceded	NULL
by	NULL
the	NULL
rapid	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
19	NULL
,	NULL
35	NULL
,	NULL
80	NULL
,	NULL
81	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
role	NULL
,	NULL
if	NULL
any	NULL
,	NULL
that	NULL
phosphorylation	NULL
plays	NULL
in	NULL
regulating	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
remains	NULL
unclear	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
its	NULL
transient	NULL
nuclear	NULL
expression	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
,	NULL
NF-kB	NULL
is	NULL
constitutively	NULL
activated	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
(	NULL
6	NULL
,	NULL
47	NULL
,	NULL
69	NULL
)	NULL
.	NULL

This	NULL
virus-host	NULL
interplay	NULL
confers	NULL
Tax	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
802	NULL
Rudolph	NULL
Light	NULL
Hall	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232-0295	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
615	NULL
)	NULL
343-1548	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
615	NULL
)	NULL
343-4726	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
ballardw	NULL
@	NULL
ctrvax.vanderbilt	NULL
.	NULL

edu	NULL
.	NULL

2809	NULL
inducibility	NULL
to	NULL
a	NULL
set	NULL
of	NULL
NF-	NULL
«	NULL
xB-responsive	NULL
cellular	NULL
genes	NULL
that	NULL
are	NULL
normally	NULL
transcribed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
31	NULL
and	NULL
32	NULL
)	NULL
.	NULL

This	NULL
set	NULL
includes	NULL
the	NULL
transcription	NULL
units	NULL
encoding	NULL
IL-2	NULL
and	NULL
the	NULL
alpha	NULL
subunit	NULL
of	NULL
its	NULL
high-affinity	NULL
receptor	NULL
(	NULL
IL-2Ra	NULL
)	NULL
,	NULL
which	NULL
together	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
normal	NULL
growth	NULL
signal	NULL
transduction	NULL
(	NULL
21	NULL
,	NULL
40	NULL
,	NULL
44	NULL
,	NULL
51	NULL
,	NULL
76	NULL
)	NULL
.	NULL

The	NULL
Tax	NULL
protein	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
5	NULL
'	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
tandem	NULL
NF-kB	NULL
binding	NULL
sites	NULL
(	NULL
15	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
Tax-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
is	NULL
temporally	NULL
associated	NULL
with	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
42	NULL
,	NULL
82	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

have	NULL
demonstrated	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
Tax	NULL
is	NULL
partially	NULL
inhibited	NULL
by	NULL
select	NULL
antioxidants	NULL
that	NULL
block	NULL
physiologic	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
71	NULL
,	NULL
72	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
findings	NULL
suggest	NULL
a	NULL
convergent	NULL
mechanism	NULL
for	NULL
NF-kB	NULL
induction	NULL
involving	NULL
the	NULL
inactivation	NULL
of	NULL
IxBa	NULL
,	NULL
an	NULL
explanation	NULL
for	NULL
how	NULL
this	NULL
cytoplasmic	NULL
inhibitor	NULL
integrates	NULL
seemingly	NULL
disparate	NULL
viral	NULL
and	NULL
immune	NULL
activation	NULL
signals	NULL
has	NULL
remained	NULL
unknown	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
we	NULL
devised	NULL
an	NULL
expression	NULL
system	NULL
that	NULL
permits	NULL
functional	NULL
incorporation	NULL
of	NULL
ectopic	NULL
forms	NULL
of	NULL
IxBa	NULL
into	NULL
the	NULL
endogenous	NULL
NF-kB	NULL
signaling	NULL
pathway	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Using	NULL
this	NULL
in	NULL
vivo	NULL
approach	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
signal	NULL
response	NULL
(	NULL
SR	NULL
)	NULL
domain	NULL
in	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
IxBa	NULL
that	NULL
is	NULL
required	NULL
not	NULL
only	NULL
for	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
mediated	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
but	NULL
also	NULL
for	NULL
transient	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
via	NULL
signal	NULL
transduction	NULL
pathways	NULL
linked	NULL
to	NULL
T-cell	NULL
antigen	NULL
and	NULL
cytokine	NULL
receptors	NULL
.	NULL

Mutations	NULL
introduced	NULL
at	NULL
two	NULL
serine	NULL
residues	NULL
within	NULL
this	NULL
regulatory	NULL
domain	NULL
produced	NULL
constitutive	NULL
repressors	NULL
of	NULL
NF-kB-directed	NULL
transcrip-tion	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
agonists	NULL
that	NULL
normally	NULL
induce	NULL
the	NULL
2810	NULL
BROCKMAN	NULL
ET	NULL
AL	NULL
.	NULL

degradation	NULL
of	NULL
IxBa	NULL
and	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

This	NULL
dominant-negative	NULL
phenotype	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
escape	NULL
of	NULL
IxBa	NULL
from	NULL
proteolytic	NULL
breakdown	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
the	NULL
SR	NULL
domain	NULL
may	NULL
affect	NULL
the	NULL
induced	NULL
entry	NULL
of	NULL
IxB	NULL
into	NULL
its	NULL
degradative	NULL
pathway	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

Complementary	NULL
DNAs	NULL
encoding	NULL
full-length	NULL
wild-type	NULL
and	NULL
mutant	NULL
forms	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
(	NULL
77	NULL
)	NULL
,	NULL
human	NULL
RelA	NULL
(	NULL
67	NULL
)	NULL
,	NULL
and	NULL
human	NULL
IxBa	NULL
(	NULL
33	NULL
)	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
polylinker	NULL
of	NULL
the	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
pCMV4	NULL
(	NULL
2	NULL
)	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
immediate-early	NULL
promoter	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
plasmids	NULL
contained	NULL
either	NULL
the	NULL
full-length	NULL
HTLV-1	NULL
LTR	NULL
(	NULL
78	NULL
)	NULL
,	NULL
HIV-1	NULL
LTR	NULL
(	NULL
78	NULL
)	NULL
,	NULL
c-fos	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
,	NULL
IL-2Ra	NULL
promoter	NULL
(	NULL
nucleotides	NULL
-317	NULL
to	NULL
+109	NULL
)	NULL
(	NULL
49	NULL
)	NULL
,	NULL
or	NULL
HIV	NULL
«	NULL
B	NULL
enhancer	NULL
cassette	NULL
linked	NULL
to	NULL
a	NULL
heterologous	NULL
TATA	NULL
box	NULL
(	NULL
79	NULL
)	NULL
.	NULL

Deletion	NULL
mutants	NULL
of	NULL
IxBa	NULL
encoding	NULL
amino	NULL
acids	NULL
37	NULL
to	NULL
317	NULL
(	NULL
IxBaAN	NULL
)	NULL
and	NULL
1	NULL
to	NULL
242	NULL
(	NULL
IxBaAC	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
PCR	NULL
using	NULL
specific	NULL
oligonucleotide	NULL
primers	NULL
(	NULL
5'-GGGAAGCTTCTCGTCCGCGCCATGA	NULL
AAGACGAGGAGTACGAG-3	NULL
'	NULL
and	NULL
5'-GGTCTAGATCATAACGTCAGAC	NULL
GCTGGCCT-3	NULL
'	NULL
for	NULL
IxBeAN	NULL
;	NULL
CCAG-3	NULL
'	NULL
and	NULL
5	NULL
%	NULL
-GGTCTAGATCAATCAGCCCCACACTTCAACAG-3	NULL
'	NULL
for	NULL
IxBaAC	NULL
)	NULL
and	NULL
the	NULL
wild-type	NULL
IxBa	NULL
(	NULL
IxBaWT	NULL
)	NULL
cDNA	NULL
(	NULL
33	NULL
)	NULL
as	NULL
a	NULL
template	NULL
.	NULL

Amplified	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
Xbel	NULL
,	NULL
purified	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
ligated	NULL
into	NULL
the	NULL
pCMV4	NULL
polylinker	NULL
.	NULL

Site-directed	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
full-length	NULL
IxBa	NULL
cDNA	NULL
by	NULL
using	NULL
the	NULL
phosphorothioate	NULL
method	NULL
and	NULL
oligonucleotide	NULL
primers	NULL
that	NULL
introduced	NULL
diagnostic	NULL
restriction	NULL
sites	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Epitope-tagged	NULL
derivatives	NULL
of	NULL
select	NULL
IxBa	NULL
mutants	NULL
were	NULL
constructed	NULL
by	NULL
PCR-assisted	NULL
amplification	NULL
with	NULL
5	NULL
'	NULL
primers	NULL
that	NULL
fused	NULL
sequences	NULL
encoding	NULL
the	NULL
FLAG	NULL
epitope	NULL
(	NULL
13	NULL
,	NULL
64	NULL
)	NULL
in	NULL
frame	NULL
with	NULL
N-terminal	NULL
coding	NULL
sequences	NULL
of	NULL
IxBa	NULL
(	NULL
5'-CCCAAGCTTCCACCATGGACTACAAAGACGATGACGATAAAATGT	NULL
TCCAGGCGGCCGAGCGC-3	NULL
'	NULL
for	NULL
I	NULL
«	NULL
BaWT	NULL
,	NULL
IxBoAC	NULL
,	NULL
IxBaS32A	NULL
,	NULL
and	NULL
IxBaS32E	NULL
;	NULL
5-CCCAAGCTTCCACCATGGACTACAAAGACGATGACGATAAAAT	NULL
GAAAGACGAGGAGTACGAGC-3	NULL
'	NULL
for	NULL
IxBaAN	NULL
)	NULL
.	NULL

Amplified	NULL
products	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
Xbel	NULL
polylinker	NULL
sites	NULL
of	NULL
pCMV4	NULL
.	NULL

Cell	NULL
culture	NULL
,	NULL
transfections	NULL
,	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Jurkat	NULL
T	NULL
lymphocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Approximately	NULL
10	NULL
``	NULL
cells	NULL
suspended	NULL
in	NULL
RPMI	NULL
(	NULL
300	NULL
l	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
(	NULL
250	NULL
V	NULL
,	NULL
960	NULL
mF	NULL
)	NULL
(	NULL
25	NULL
)	NULL
with	NULL
the	NULL
indicated	NULL
effector	NULL
and	NULL
reporter	NULL
plasmids	NULL
,	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
equipped	NULL
with	NULL
a	NULL
capacitance	NULL
extender	NULL
.	NULL

Electroporated	NULL
cells	NULL
were	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
transferred	NULL
to	NULL
5	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
,	NULL
and	NULL
then	NULL
expanded	NULL
for	NULL
48	NULL
h.	NULL
Where	NULL
indi-cated	NULL
,	NULL
cultures	NULL
were	NULL
treated	NULL
after	NULL
24	NULL
h	NULL
of	NULL
growth	NULL
with	NULL
either	NULL
TNF-	NULL
«	NULL
(	NULL
300	NULL
U/ml	NULL
;	NULL
Genzyme	NULL
)	NULL
or	NULL
combinations	NULL
of	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
;	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
1	NULL
aM	NULL
;	NULL
Calbiochem	NULL
)	NULL
for	NULL
20	NULL
h	NULL
prior	NULL
to	NULL
harvest	NULL
.	NULL

In	NULL
some	NULL
experi-ments	NULL
,	NULL
cell	NULL
cultures	NULL
were	NULL
pretreated	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
(	NULL
62	NULL
)	NULL
(	NULL
kindly	NULL
supplied	NULL
by	NULL
MyoGenics	NULL
,	NULL
Inc.	NULL
)	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
agonist	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
transfectants	NULL
,	NULL
normalized	NULL
for	NULL
protein	NULL
concentration	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
,	NULL
using	NULL
the	NULL
diffusion-based	NULL
liquid	NULL
scintillation	NULL
counting	NULL
method	NULL
described	NULL
by	NULL
Neumann	NULL
et	NULL
al	NULL
.	NULL

(	NULL
59	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
.	NULL

Cytosolic	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
transfected	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
73	NULL
)	NULL
except	NULL
that	NULL
the	NULL
detergent	NULL
lysis	NULL
buffer	NULL
was	NULL
supplemented	NULL
with	NULL
an	NULL
extensive	NULL
cocktail	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
and	NULL
equilibrated	NULL
in	NULL
ELB	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
N-2-hydroxycthylpiperazinec-V'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
]	NULL
,	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet-P40	NULL
)	NULL
.	NULL

Epitope-tagged	NULL
IxBa	NULL
was	NULL
isolated	NULL
from	NULL
these	NULL
cytosolic	NULL
extracts	NULL
by	NULL
incubation	NULL
with	NULL
20	NULL
wl	NULL
of	NULL
agarose	NULL
beads	NULL
conjugated	NULL
to	NULL
monoclonal	NULL
anti-FLAG	NULL
M2	NULL
antibody	NULL
(	NULL
IBI-Kodak	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ELB	NULL
buffer	NULL
,	NULL
heat	NULL
denatured	NULL
in	NULL
4	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-10	NULL
%	NULL
B-mercaptocthanol	NULL
,	NULL
fractionated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
elec-trophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
,	NULL
and	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
a	NULL
polyvinylidene	NULL
di-fluoride	NULL
membrane	NULL
(	NULL
Dupont	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
blocked	NULL
(	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temper-ature	NULL
)	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
containing	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
5	NULL
%	NULL
powdered	NULL
milk	NULL
(	NULL
BLOTTO	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
a	NULL
rabbit	NULL
antipeptide	NULL
antiserum	NULL
specific	NULL
for	NULL
either	NULL
IxBa	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
28	NULL
and	NULL
229	NULL
to	NULL
317	NULL
)	NULL
or	NULL
RelA	NULL
(	NULL
amino	NULL
acids	NULL
529	NULL
to	NULL
551	NULL
)	NULL
.	NULL

Immunoreactive	NULL
polypeptides	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
donkey	NULL
anti-rabbit	NULL
immunoglobulin	NULL
G	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
in	NULL
an	NULL
enhanced	NULL
chemi-luminescence	NULL
system	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
.	NULL

Nuclear	NULL
fractions	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T-cell	NULL
transfectants	NULL
by	NULL
high-salt	NULL
extraction	NULL
(	NULL
73	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
P-radiolabeled	NULL
oligonucleotide	NULL
duplex	NULL
derived	NULL
from	NULL
xB	NULL
enhancer	NULL
sequences	NULL
in	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
(	NULL
5'-CAACGGCAGGGGAATTCCCCTCTCCTT-3	NULL
'	NULL
)	NULL
(	NULL
8	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
reaction	NULL
mixtures	NULL
(	NULL
20	NULL
pl	NULL
)	NULL
contained	NULL
5	NULL
pg	NULL
of	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
,	NULL
2	NULL
mg	NULL
of	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
buffered	NULL
in	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-5	NULL
%	NULL
glycerol-1	NULL
mM	NULL
EDTA-1	NULL
%	NULL
Nonidet	NULL
P-40-5	NULL
mM	NULL
dithioth-reitol	NULL
.	NULL

Approximately	NULL
10	NULL
fmol	NULL
(	NULL
200,000	NULL
epm	NULL
)	NULL
of	NULL
radiolabeled	NULL
probe	NULL
was	NULL
used	NULL
per	NULL
reaction	NULL
.	NULL

Resultant	NULL
nucleoprotein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Relative	NULL
CAT	NULL
Activity	NULL
(	NULL
Fold	NULL
Induction	NULL
)	NULL
nos	NULL
os	NULL
a	NULL
g	NULL
&	NULL
o	NULL
O	NULL
o	NULL
O	NULL
_s	NULL
o	NULL
to	NULL
ke	NULL
,	NULL
x5	NULL
,	NULL
5	NULL
My	NULL
,	NULL
4	NULL
Q	NULL
’	NULL
ho	NULL
,	NULL
ty	NULL
y	NULL
``	NULL
o	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
Tax-responsive	NULL
domain	NULL
in	NULL
IxBa	NULL
«	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
HIV-	NULL
«	NULL
B-CAT	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
and	NULL
equivalent	NULL
doses	NULL
(	NULL
2.5	NULL
pg	NULL
)	NULL
of	NULL
the	NULL
indicated	NULL
pCMV4-based	NULL
IxBa	NULL
expression	NULL
vectors	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
normalized	NULL
for	NULL
total	NULL
protein	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Results	NULL
from	NULL
five	NULL
independent	NULL
transfections	NULL
are	NULL
reported	NULL
as	NULL
the	NULL
mean	NULL
fold	NULL
induction	NULL
(	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
)	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
Tax-expressing	NULL
versus	NULL
Tax-deficient	NULL
cells	NULL
.	NULL

RESULTS	NULL
IxBa	NULL
is	NULL
a	NULL
cellular	NULL
target	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Recent	NULL
primary	NULL
structural	NULL
analyses	NULL
of	NULL
human	NULL
IxBa	NULL
have	NULL
indicated	NULL
that	NULL
this	NULL
cytoplasmic	NULL
inhibitor	NULL
contains	NULL
a	NULL
central	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
73	NULL
to	NULL
242	NULL
)	NULL
composed	NULL
of	NULL
five	NULL
ankyrin	NULL
repeat	NULL
motifs	NULL
,	NULL
a	NULL
C-terminal	NULL
PEST	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
243	NULL
to	NULL
317	NULL
)	NULL
characteristic	NULL
of	NULL
many	NULL
short-lived	NULL
proteins	NULL
,	NULL
and	NULL
an	NULL
N-terminal	NULL
domain	NULL
of	NULL
unknown	NULL
biological	NULL
function	NULL
(	NULL
33	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IKxBa	NULL
«	NULL
is	NULL
required	NULL
for	NULL
Tax-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
we	NULL
initially	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
mediate	NULL
«	NULL
B-specific	NULL
transcription	NULL
in	NULL
cells	NULL
reconstituted	NULL
with	NULL
deletion	NULL
mutants	NULL
of	NULL
IxBa	NULL
that	NULL
contained	NULL
a	NULL
fully	NULL
intact	NULL
ankyrin	NULL
repeat	NULL
domain	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
human	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
these	NULL
truncated	NULL
forms	NULL
of	NULL
IxBa	NULL
,	NULL
HTLV-1	NULL
Tax	NULL
,	NULL
and	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
from	NULL
the	NULL
HIV	NULL
enhancer	NULL
(	NULL
HIV-	NULL
«	NULL
kB-CAT	NULL
)	NULL
(	NULL
55	NULL
,	NULL
79	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
Tax	NULL
induced	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
HIV-kB	NULL
reporter	NULL
gene	NULL
at	NULL
least	NULL
50-fold	NULL
over	NULL
basal	NULL
levels	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ectopic	NULL
IxBa	NULL
.	NULL

This	NULL
activity	NULL
persisted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
IxBaWT	NULL
or	NULL
a	NULL
mutant	NULL
of	NULL
IxBa	NULL
lacking	NULL
the	NULL
C-terminal	NULL
PEST	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
243	NULL
to	NULL
317	NULL
;	NULL
IxBaAC	NULL
)	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
to	NULL
IxBaWT	NULL
,	NULL
identical	NULL
doses	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
of	NULL
a	NULL
deletion	NULL
mutant	NULL
lacking	NULL
the	NULL
N-terminal	NULL
36	NULL
amino	NULL
acids	NULL
(	NULL
IxBaAN	NULL
)	NULL
almost	NULL
completely	NULL
abolished	NULL
the	NULL
Tax	NULL
response	NULL
.	NULL

Results	NULL
of	NULL
immunoblotting	NULL
studies	NULL
indicated	NULL
that	NULL
the	NULL
IxBaWT	NULL
and	NULL
IxBoAN	NULL
proteins	NULL
were	NULL
expressed	NULL
at	NULL
comparable	NULL
steady-state	NULL
levels	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
titration	NULL
experiments	NULL
indicated	NULL
that	NULL
10-to	NULL
20-fold	NULL
higher	NULL
concentrations	NULL
of	NULL
IxBaWT	NULL
than	NULL
of	NULL
IxBaAN	NULL
were	NULL
required	NULL
to	NULL
achieve	NULL
half-maximal	NULL
inhibition	NULL
of	NULL
this	NULL
re-sponse	NULL
,	NULL
thus	NULL
precluding	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
divergent	NULL
functional	NULL
effects	NULL
were	NULL
due	NULL
to	NULL
slight	NULL
variations	NULL
in	NULL
effector	NULL
plasmid	NULL
input	NULL
.	NULL

Conditional	NULL
repression	NULL
of	NULL
Tax-dependent	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
Tax	NULL
can	NULL
also	NULL
interface	NULL
with	NULL
distinct	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
serum-responsive	NULL
factor	NULL
(	NULL
26	NULL
)	NULL
and	NULL
members	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-responsive	NULL
element-binding	NULL
pro-tein/activating	NULL
transcription	NULL
factor	NULL
(	NULL
CREB/ATF	NULL
)	NULL
family	NULL
(	NULL
83	NULL
,	NULL
89	NULL
)	NULL
,	NULL
thus	NULL
expanding	NULL
the	NULL
range	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
under	NULL
Tax	NULL
control	NULL
.	NULL

In	NULL
light	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
the	NULL
altered	NULL
in	NULL
vivo	NULL
function	NULL
of	NULL
IxBa	NULL
produced	NULL
by	NULL
this	NULL
N-terminal	NULL
deletion	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
could	NULL
reflect	NULL
the	NULL
inhibition	NULL
of	NULL
auxiliary	NULL
components	NULL
of	NULL
the	NULL
cellular	NULL
transcriptional	NULL
machinery	NULL
other	NULL
than	NULL
NF-KB	NULL
.	NULL

Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
HTLV-1	NULL
LTR	NULL
7	NULL
Relative	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
HIV	NULL
LTR	NULL
10	NULL
Effector	NULL
Plasmid	NULL
(	NULL
ug	NULL
)	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Conditional	NULL
repression	NULL
of	NULL
Tax-dependent	NULL
transcription	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
,	NULL
graded	NULL
amounts	NULL
of	NULL
IxBaAN	NULL
effector	NULL
plasmid	NULL
,	NULL
and	NULL
a	NULL
CAT	NULL
reporter	NULL
construct	NULL
under	NULL
transcriptional	NULL
control	NULL
of	NULL
either	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
1	NULL
ag	NULL
)	NULL
,	NULL
HTLV-1	NULL
LTR	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
,	NULL
c-fos	NULL
promoter	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
,	NULL
or	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
.	NULL

Input	NULL
DNA	NULL
for	NULL
all	NULL
transfections	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
was	NULL
normalized	NULL
by	NULL
addition	NULL
of	NULL
blank	NULL
pCMV4	NULL
expression	NULL
vector	NULL
.	NULL

For	NULL
each	NULL
titration	NULL
point	NULL
(	NULL
r	NULL
=	NULL
3	NULL
)	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
reporter	NULL
gene	NULL
activity	NULL
over	NULL
basal	NULL
levels	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
percentage	NULL
of	NULL
CAT	NULL
activity	NULL
measured	NULL
in	NULL
control	NULL
cells	NULL
lacking	NULL
the	NULL
IxBaAN	NULL
expression	NULL
vector	NULL
.	NULL

In	NULL
IxBoAN-deficient	NULL
cells	NULL
,	NULL
the	NULL
Tax-dependent	NULL
increases	NULL
in	NULL
CAT	NULL
activity	NULL
over	NULL
basal	NULL
levels	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
were	NULL
21.6	NULL
+	NULL
3.3	NULL
(	NULL
HTLV-1	NULL
LTR	NULL
)	NULL
,	NULL
8.0	NULL
+	NULL
2.8	NULL
(	NULL
HIV	NULL
LTR	NULL
)	NULL
,	NULL
10.6	NULL
+	NULL
2.7	NULL
(	NULL
c-fos	NULL
promoter	NULL
)	NULL
,	NULL
and	NULL
10.7	NULL
+	NULL
0.2	NULL
(	NULL
IL-2R	NULL
«	NULL
promoter	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
interaction	NULL
,	NULL
titration	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
IxBaAN	NULL
effector	NULL
plasmid	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
cotransfected	NULL
with	NULL
Tax	NULL
and	NULL
distinct	NULL
Tax-responsive	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
various	NULL
naturally	NULL
occurring	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
synthetic	NULL
HIV-	NULL
«	NULL
kB-CAT	NULL
construct	NULL
,	NULL
IxBaAN	NULL
potently	NULL
repressed	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
full-length	NULL
HIV	NULL
LTR	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IxBoAN	NULL
failed	NULL
to	NULL
significantly	NULL
down-regulate	NULL
transcription	NULL
directed	NULL
from	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
,	NULL
which	NULL
responds	NULL
to	NULL
Tax	NULL
by	NULL
a	NULL
CREB/ATF-dependent	NULL
mechanism	NULL
(	NULL
83	NULL
,	NULL
89	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
Tax-induced	NULL
transcription	NULL
from	NULL
the	NULL
xB-responsive	NULL
IL-Z2Ra	NULL
promoter	NULL
was	NULL
also	NULL
attenuated	NULL
(	NULL
>	NULL
90	NULL
%	NULL
)	NULL
A	NULL
Anti-lkBa	NULL
Anti-RelA	NULL
REGULATION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
2811	NULL
in	NULL
cells	NULL
expressing	NULL
low	NULL
doses	NULL
of	NULL
IxB	NULL
«	NULL
eAN	NULL
.	NULL

However	NULL
,	NULL
higher	NULL
doses	NULL
of	NULL
this	NULL
deletion	NULL
mutant	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
led	NULL
to	NULL
only	NULL
modest	NULL
inhibitory	NULL
effects	NULL
(	NULL
<	NULL
15	NULL
%	NULL
)	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
,	NULL
a	NULL
response	NULL
mediated	NULL
primarily	NULL
through	NULL
the	NULL
indirect	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
an	NULL
intrinsic	NULL
serum	NULL
response	NULL
factor-binding	NULL
site	NULL
(	NULL
26	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
promoter-specific	NULL
repression	NULL
confirmed	NULL
that	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
IxBa	NULL
is	NULL
selectively	NULL
involved	NULL
in	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
deregulates	NULL
the	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
xB-dependent	NULL
transcription	NULL
units	NULL
.	NULL

In	NULL
vivo	NULL
interactions	NULL
between	NULL
ectopic	NULL
IxBa	NULL
and	NULL
endogenous	NULL
RelA	NULL
.	NULL

The	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
transactivator	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
serves	NULL
as	NULL
the	NULL
high-affinity	NULL
receptor	NULL
for	NULL
IxBa	NULL
(	NULL
5	NULL
,	NULL
11	NULL
,	NULL
27	NULL
,	NULL
86	NULL
)	NULL
.	NULL

This	NULL
dynamic	NULL
interplay	NULL
between	NULL
RelA	NULL
and	NULL
IxBa	NULL
thus	NULL
governs	NULL
the	NULL
subcellular	NULL
distribution	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-kB	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
these	NULL
deletion	NULL
mutants	NULL
of	NULL
IxBa	NULL
interacted	NULL
functionally	NULL
with	NULL
RelA	NULL
,	NULL
immunoprecipitation	NULL
and	NULL
gel	NULL
retardation	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
these	NULL
T-cell	NULL
transfectants	NULL
.	NULL

To	NULL
distinguish	NULL
ectopic	NULL
from	NULL
endogenous	NULL
IxBa	NULL
in	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
IxBa	NULL
cDNAs	NULL
that	NULL
were	NULL
fused	NULL
in	NULL
frame	NULL
with	NULL
sequences	NULL
encoding	NULL
the	NULL
FLAG	NULL
epitope	NULL
(	NULL
13	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Results	NULL
from	NULL
CAT	NULL
assays	NULL
indicated	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
epitope	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
functional	NULL
phenotype	NULL
of	NULL
these	NULL
IxBa	NULL
constructs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
these	NULL
epitope-tagged	NULL
derivatives	NULL
of	NULL
IxBa	NULL
were	NULL
efficiently	NULL
expressed	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
consistent	NULL
with	NULL
prior	NULL
in	NULL
vitro	NULL
studies	NULL
(	NULL
34	NULL
,	NULL
39	NULL
)	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
completely	NULL
disrupted	NULL
its	NULL
RelA-binding	NULL
function	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
IxBa	NULL
,	NULL
which	NULL
blocked	NULL
the	NULL
Tax	NULL
transcriptional	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
retained	NULL
the	NULL
capacity	NULL
to	NULL
form	NULL
stable	NULL
complexes	NULL
with	NULL
endogenous	NULL
RelA	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
these	NULL
complexes	NULL
were	NULL
functionally	NULL
latent	NULL
but	NULL
competent	NULL
for	NULL
induction	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
RelA	NULL
and	NULL
graded	NULL
doses	NULL
of	NULL
each	NULL
IxBa	NULL
deletion	NULL
mutant	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
then	NULL
prepared	NULL
from	NULL
recipient	NULL
cells	NULL
and	NULL
analyzed	NULL
for	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
(	NULL
pCMV4	NULL
panel	NULL
)	NULL
,	NULL
two	NULL
nucleoprotein	NULL
complexes	NULL
were	NULL
detected	NULL
with	NULL
extracts	NULL
from	NULL
control	NULL
cells	NULL
expressing	NULL
ectopic	NULL
RelA	NULL
.	NULL

Results	NULL
of	NULL
B	NULL
102	NULL
8	NULL
%	NULL
4	NULL
5	NULL
C	NULL
pomve	NULL
wT	NULL
AN	NULL
|	NULL
1	NULL
1	NULL
|	NULL
-	NULL
a	NULL
@	NULL
<	NULL
»	NULL
O	NULL
Ty	NULL
--	NULL
a	NULL
T3	NULL
Ty	NULL
tor	NULL
3	NULL
400	NULL
506	NULL
Io	NULL
PCMV4	NULL
am	NULL
as	NULL
@	NULL
es	NULL
@	NULL
_	NULL
=	NULL
!	NULL

:	NULL
5	NULL
5	NULL
5	NULL
5	NULL
97	NULL
-	NULL
-	NULL
b=	NULL
}	NULL
=	NULL
==	NULL
«	NULL
-	NULL
»	NULL
68	NULL
-	NULL
=-	NULL
Gua	NULL
aoc	NULL
WT	NULL
du	NULL
=	NULL
>	NULL
46	NULL
-	NULL
s=	NULL
-	NULL
»	NULL
1	NULL
%	NULL
Tee	NULL
31	NULL
-	NULL
-	NULL
'	NULL
«	NULL
@	NULL
38-	NULL
TAK	NULL
-	NULL
$	NULL
o	NULL
-o	NULL
jo	NULL
oo-	NULL
4+	NULL
na	NULL
§	NULL
YN	NULL
aao	NULL
,	NULL
Ay	NULL
ats	NULL
tp	NULL
Aip	NULL
-	NULL
``	NULL
ols	NULL
*s	NULL
4	NULL
b	NULL
ns	NULL
,	NULL
471	NULL
,	NULL
'	NULL
o	NULL
G	NULL
%	NULL
&	NULL
%	NULL
[	NULL
kl/6a-	NULL
0G	NULL
éQ	NULL
4	NULL
~d	NULL
``	NULL
o	NULL
O	NULL
*	NULL
~	NULL
4	NULL
%	NULL
*	NULL
>	NULL
4	NULL
To	NULL
Vector	NULL
(	NULL
ug	NULL
)	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Biochemical	NULL
properties	NULL
of	NULL
IxBa	NULL
deletion	NULL
mutants	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Association	NULL
with	NULL
endogenous	NULL
RelA	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
epitope-tagged	NULL
derivatives	NULL
of	NULL
the	NULL
indicated	NULL
IxBa	NULL
cDNA	NULL
expression	NULL
vectors	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
or	NULL
with	NULL
the	NULL
unmodified	NULL
parental	NULL
vector	NULL
(	NULL
pCMV4	NULL
;	NULL
20	NULL
ug	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
complexes	NULL
containing	NULL
ectopic	NULL
IxBa	NULL
were	NULL
isolated	NULL
by	NULL
immunoaffinity	NULL
chromatography	NULL
,	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
a	NULL
peptide-specific	NULL
antiserum	NULL
for	NULL
either	NULL
IxBa	NULL
«	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
29	NULL
and	NULL
289	NULL
to	NULL
317	NULL
)	NULL
or	NULL
RelA	NULL
(	NULL
amino	NULL
acids	NULL
529	NULL
to	NULL
551	NULL
)	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Inhibition	NULL
of	NULL
nuclear	NULL
ReIA/NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
cDNA	NULL
expression	NULL
vector	NULL
encoding	NULL
human	NULL
RelA	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
and	NULL
graded	NULL
doses	NULL
of	NULL
the	NULL
indicated	NULL
IxBa	NULL
expression	NULL
vectors	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
from	NULL
transfectants	NULL
were	NULL
added	NULL
to	NULL
DNA	NULL
binding	NULL
reaction	NULL
mixtures	NULL
containing	NULL
a	NULL
**P-labeled	NULL
palindromic	NULL
kB	NULL
probe	NULL
(	NULL
xB-pd	NULL
)	NULL
(	NULL
8	NULL
)	NULL
and	NULL
analyzed	NULL
on	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
containing	NULL
RelA	NULL
homodimers	NULL
(	NULL
upper	NULL
arrow	NULL
)	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50/ReIA	NULL
heterodimers	NULL
(	NULL
lower	NULL
arrow	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Induction	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B/ReIA	NULL
activity	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
RelA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
,	NULL
Tax	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
IxBa	NULL
constructs	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
growth	NULL
,	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
cycloheximide	NULL
(	NULL
50	NULL
pg/ml	NULL
!	NULL
)	NULL

for	NULL
2	NULL
h	NULL
in	NULL
order	NULL
to	NULL
prevent	NULL
the	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
IxBa	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
containing	NULL
RelA	NULL
homodimers	NULL
and	NULL
p50/ReIA	NULL
(	NULL
NF-kB	NULL
)	NULL
heterodimers	NULL
are	NULL
indicated	NULL
with	NULL
arrows	NULL
.	NULL

2812	NULL
BROCKMAN	NULL
ET	NULL
AL	NULL
.	NULL

DNA-protein	NULL
cross-linking	NULL
and	NULL
antibody	NULL
binding	NULL
studies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
indicated	NULL
that	NULL
the	NULL
upper	NULL
complex	NULL
contained	NULL
RelA	NULL
homodimers	NULL
and	NULL
the	NULL
lower	NULL
complex	NULL
contained	NULL
p50/ReIA	NULL
(	NULL
NF-kB	NULL
)	NULL
heterodimers	NULL
,	NULL
which	NULL
form	NULL
as	NULL
a	NULL
result	NULL
of	NULL
RelA-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB1	NULL
gene	NULL
encoding	NULL
pSO0	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
its	NULL
defect	NULL
in	NULL
RelA	NULL
binding	NULL
,	NULL
IxBaAC	NULL
failed	NULL
to	NULL
inhibit	NULL
these	NULL
«	NULL
B-specific	NULL
activities	NULL
when	NULL
expressed	NULL
over	NULL
a	NULL
wide	NULL
concentration	NULL
range	NULL
(	NULL
AC	NULL
panel	NULL
)	NULL
.	NULL

However	NULL
,	NULL
even	NULL
at	NULL
low	NULL
dosage	NULL
,	NULL
the	NULL
wild-type	NULL
and	NULL
N-terminally	NULL
deleted	NULL
forms	NULL
of	NULL
IxBa	NULL
completely	NULL
blocked	NULL
both	NULL
of	NULL
these	NULL
DNA	NULL
binding	NULL
activities	NULL
(	NULL
WT	NULL
and	NULL
AN	NULL
panels	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
coexpression	NULL
with	NULL
HTLV-1	NULL
Tax	NULL
led	NULL
to	NULL
efficient	NULL
inactivation	NULL
of	NULL
IxBaWT	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
accumulation	NULL
of	NULL
functional	NULL
RelA	NULL
and	NULL
NF-kB	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Tax	NULL
failed	NULL
to	NULL
activate	NULL
latent	NULL
complexes	NULL
containing	NULL
the	NULL
N-terminally	NULL
truncated	NULL
inhibitor	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
IxBa	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
formation	NULL
of	NULL
latent	NULL
NF-kB	NULL
complexes	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
N-terminal	NULL
segment	NULL
of	NULL
IkBa	NULL
(	NULL
the	NULL
SR	NULL
domain	NULL
)	NULL
subserves	NULL
a	NULL
distinct	NULL
regulatory	NULL
function	NULL
that	NULL
is	NULL
required	NULL
for	NULL
Tax-mediated	NULL
induction	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
specifies	NULL
determinants	NULL
for	NULL
targeted	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
.	NULL

The	NULL
transient	NULL
induction	NULL
of	NULL
NF-kB	NULL
during	NULL
T-cell	NULL
activation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
prior	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
10	NULL
,	NULL
19	NULL
,	NULL
80	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
,	NULL
which	NULL
lacks	NULL
determinants	NULL
for	NULL
NF-xB	NULL
binding	NULL
,	NULL
might	NULL
regulate	NULL
the	NULL
stability	NULL
of	NULL
this	NULL
inhibitor	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypoth-esis	NULL
,	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
epitope-tagged	NULL
IxBa	NULL
protein	NULL
and	NULL
its	NULL
N-terminally	NULL
deleted	NULL
counterpart	NULL
were	NULL
examined	NULL
in	NULL
Tax-expressing	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
provide	NULL
stringent	NULL
control	NULL
for	NULL
these	NULL
ex-periments	NULL
,	NULL
we	NULL
also	NULL
used	NULL
expression	NULL
vectors	NULL
for	NULL
Tax	NULL
containing	NULL
missense	NULL
mutations	NULL
that	NULL
selectively	NULL
disrupt	NULL
its	NULL
ability	NULL
to	NULL
access	NULL
either	NULL
the	NULL
CREB/ATF	NULL
(	NULL
Tax-M47	NULL
)	NULL
or	NULL
the	NULL
NF-kB/Rel	NULL
(	NULL
Tax-M22	NULL
)	NULL
transcription	NULL
factor	NULL
pathway	NULL
(	NULL
77	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Tax-M22	NULL
fails	NULL
to	NULL
induce	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
,	NULL
whereas	NULL
the	NULL
Tax-M47	NULL
mutant	NULL
is	NULL
fully	NULL
competent	NULL
to	NULL
execute	NULL
this	NULL
function	NULL
(	NULL
77	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
coexpression	NULL
of	NULL
IxBa	NULL
with	NULL
wild-type	NULL
Tax	NULL
led	NULL
to	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
cytoplasmic	NULL
IxBa	NULL
protein	NULL
relative	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
Tax-deficient	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
their	NULL
differing	NULL
capacities	NULL
to	NULL
induce	NULL
NF-kB	NULL
,	NULL
the	NULL
degradative	NULL
loss	NULL
of	NULL
ectopic	NULL
IxBa	NULL
was	NULL
also	NULL
evident	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
Tax-	NULL
M47	NULL
mutant	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
Tax-M22	NULL
mutant	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
destabilizing	NULL
effects	NULL
of	NULL
Tax	NULL
on	NULL
wild-type	NULL
IxBa	NULL
,	NULL
Tax	NULL
and	NULL
Tax-M47	NULL
both	NULL
failed	NULL
to	NULL
mediate	NULL
a	NULL
decline	NULL
in	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
the	NULL
IxBaAN	NULL
protein	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
contains	NULL
requisite	NULL
regulatory	NULL
determinants	NULL
not	NULL
only	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
Tax	NULL
but	NULL
also	NULL
for	NULL
Tax-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
IxBa	NULL
is	NULL
phosphorylated	NULL
prior	NULL
to	NULL
its	NULL
degradative	NULL
loss	NULL
during	NULL
normal	NULL
T-cell	NULL
activation	NULL
(	NULL
10	NULL
,	NULL
19	NULL
,	NULL
52	NULL
,	NULL
57	NULL
,	NULL
81	NULL
)	NULL
.	NULL

This	NULL
labile	NULL
phosphorylated	NULL
form	NULL
of	NULL
IkBa	NULL
is	NULL
readily	NULL
detected	NULL
as	NULL
a	NULL
more	NULL
slowly	NULL
migrating	NULL
electrophoretic	NULL
variant	NULL
that	NULL
accumulates	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
inhibitors	NULL
of	NULL
the	NULL
proteasome	NULL
degradation	NULL
pathway	NULL
(	NULL
62	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
increased	NULL
stability	NULL
of	NULL
IxBaAN	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
altered	NULL
pattern	NULL
of	NULL
phosphorylation	NULL
,	NULL
we	NULL
used	NULL
the	NULL
previously	NULL
described	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
(	NULL
62	NULL
)	NULL
in	NULL
an	NULL
attempt	NULL
to	NULL
prevent	NULL
Tax-induced	NULL
turnover	NULL
of	NULL
ectopic	NULL
IxBa	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
a	NULL
modified	NULL
form	NULL
of	NULL
IxBaWT	NULL
was	NULL
weakly	NULL
detected	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
MG132	NULL
alone	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
presumably	NULL
as	NULL
a	NULL
result	NULL
of	NULL
arrest	NULL
of	NULL
basal	NULL
turnover	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-kB	NULL
inducer	NULL
.	NULL

Expression	NULL
of	NULL
this	NULL
electrophoretic	NULL
variant	NULL
of	NULL
IxBa	NULL
was	NULL
substantially	NULL
augmented	NULL
in	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
IxBaWT	NULL
poor	NULL
os	NULL
4	NULL
's	NULL
e	NULL
1	NULL
s	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
I	NULL
I	NULL
I	NULL
97	NULL
-	NULL
a	NULL
68—0	NULL
4°	NULL
-G	NULL
h	NULL
~	NULL
]	NULL
Ba	NULL
31	NULL
-	NULL
P	NULL
uy	NULL
s	NULL
?	NULL

.	NULL

wam	NULL
oer	NULL
ugmp	NULL
seme	NULL
ANS	NULL
20	NULL
-	NULL
_	NULL
bo	NULL
R.	NULL
Al	NULL
boob	NULL
,	NULL
«	NULL
oo	NULL
Cod	NULL
4	NULL
4	NULL
to	NULL
5	NULL
4	NULL
3	NULL
£	NULL
%	NULL
5	NULL
a	NULL
``	NULL
a	NULL
%	NULL
o	NULL
4	NULL
,	NULL
B	NULL
IkBaWT	NULL
IkBaAN	NULL
[	NULL
G	NULL
2	NULL
s	NULL
|	NULL
[	NULL
O4	NULL
50	NULL
6	NULL
|	NULL
I	NULL
I	NULL
I	NULL
1	NULL
I	NULL
I	NULL
97	NULL
-	NULL
-68-	NULL
-46-	NULL
_	NULL
31-	NULL
MG132	NULL
:	NULL
-	NULL
++	NULL
-	NULL
+	NULL
+	NULL
TAK	NULL
:	NULL
-=-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

The	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
«	NULL
contains	NULL
determinants	NULL
for	NULL
Tax-induced	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
indicated	NULL
epitope-tagged	NULL
derivatives	NULL
of	NULL
IxBa	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
,	NULL
wild-type	NULL
Tax	NULL
(	NULL
Tax-WT	NULL
;	NULL
10	NULL
pg	NULL
)	NULL
,	NULL
or	NULL
Tax	NULL
mutants	NULL
(	NULL
77	NULL
)	NULL
defective	NULL
in	NULL
either	NULL
NF-kB	NULL
(	NULL
Tax-M22	NULL
)	NULL
or	NULL
CREB/ATF	NULL
(	NULL
Tax-M47	NULL
)	NULL
activating	NULL
function	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
fractionated	NULL
by	NULL
immunoaffinity	NULL
chromatography	NULL
,	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
an	NULL
IxBa-specific	NULL
antiserum	NULL
.	NULL

NS	NULL
,	NULL
nonspecific	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
plasmids	NULL
encoding	NULL
the	NULL
indicated	NULL
epitope-tagged	NULL
derivatives	NULL
of	NULL
IxBa	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
samples	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
proteosome	NULL
inhibitor	NULL
MG132	NULL
(	NULL
100	NULL
wM	NULL
,	NULL
4	NULL
h	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
cocktail	NULL
of	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
50	NULL
mM	NULL
sodium	NULL
fluoride	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
pyrophosphate	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
M	NULL
sodium	NULL
molybdate	NULL
,	NULL
50	NULL
M	NULL
zinc	NULL
chloride	NULL
,	NULL
and	NULL
20	NULL
mM	NULL
B-glycerol	NULL
phosphate	NULL
)	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-FLAG	NULL
antibody	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
probed	NULL
on	NULL
immunoblots	NULL
with	NULL
an	NULL
IxBo-specific	NULL
antiserum	NULL
.	NULL

Major	NULL
immunoreactive	NULL
species	NULL
are	NULL
indicated	NULL
with	NULL
arrows	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

cells	NULL
cotransfected	NULL
with	NULL
HTLV-1	NULL
Tax	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
despite	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
stimulate	NULL
the	NULL
breakdown	NULL
of	NULL
IxBa	NULL
in	NULL
MG132-deficient	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
selective	NULL
sensitivity	NULL
to	NULL
calf	NULL
intestinal	NULL
phosphatase	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
this	NULL
modified	NULL
form	NULL
of	NULL
IxBa	NULL
likely	NULL
derived	NULL
from	NULL
an	NULL
altered	NULL
pattern	NULL
of	NULL
phosphorylation	NULL
relative	NULL
to	NULL
the	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
IxBa	NULL
present	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

Unlike	NULL
IxBaWT	NULL
,	NULL
Tax	NULL
apparently	NULL
failed	NULL
to	NULL
mediate	NULL
the	NULL
induced	NULL
modification	NULL
of	NULL
IxBaAN	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
conspicuous	NULL
absence	NULL
of	NULL
a	NULL
characteristic	NULL
electrophoretic	NULL
doublet	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
is	NULL
essential	NULL
for	NULL
both	NULL
signal-dependent	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
this	NULL
cytoplasmic	NULL
inhibitor	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
MG132	NULL
prevents	NULL
the	NULL
breakdown	NULL
of	NULL
IxBaWT	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
implicates	NULL
the	NULL
proteasome	NULL
degradation	NULL
pathway	NULL
in	NULL
the	NULL
IxBa-dependent	NULL
mechanism	NULL
by	NULL
which	NULL
this	NULL
retroviral	NULL
gene	NULL
product	NULL
activates	NULL
NF-kB	NULL
.	NULL

Identification	NULL
of	NULL
two	NULL
regulatory	NULL
serines	NULL
in	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
.	NULL

Inspection	NULL
of	NULL
the	NULL
deduced	NULL
N-terminal	NULL
sequences	NULL
for	NULL
the	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
Relative	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
25	NULL
50	NULL
75	NULL
100	NULL
S32A/S36E	NULL
S32E/S36A	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

The	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
«	NULL
contains	NULL
regulatory	NULL
serine	NULL
sites	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
HIV-xB-CAT	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
along	NULL
with	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
Tax	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
indicated	NULL
site-directed	NULL
mutants	NULL
of	NULL
IxBa	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Tax-dependent	NULL
increases	NULL
in	NULL
reporter	NULL
gene	NULL
activity	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
induced	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
IxBaWT	NULL
(	NULL
WT	NULL
)	NULL
effector	NULL
(	NULL
fold	NULL
induction	NULL
=	NULL
29.9	NULL
+	NULL
2.6	NULL
)	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

rat	NULL
(	NULL
85	NULL
)	NULL
,	NULL
avian	NULL
(	NULL
22	NULL
)	NULL
,	NULL
porcine	NULL
(	NULL
23	NULL
)	NULL
,	NULL
and	NULL
human	NULL
(	NULL
34	NULL
)	NULL
homologs	NULL
of	NULL
IxBa	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
strictly	NULL
conserved	NULL
serines	NULL
within	NULL
the	NULL
SR	NULL
domain	NULL
(	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
in	NULL
human	NULL
IKkBa	NULL
)	NULL
that	NULL
were	NULL
absent	NULL
in	NULL
the	NULL
IxBaAN	NULL
construct	NULL
.	NULL

These	NULL
two	NULL
serines	NULL
are	NULL
positioned	NULL
within	NULL
consensus	NULL
phosphorylation	NULL
sites	NULL
for	NULL
casein	NULL
kinase	NULL
II	NULL
(	NULL
33	NULL
,	NULL
63	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
whether	NULL
either	NULL
Ser-32	NULL
or	NULL
Ser-36	NULL
constitutes	NULL
a	NULL
site	NULL
for	NULL
regulatory	NULL
phosphorylation	NULL
events	NULL
that	NULL
permit	NULL
Tax-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
a	NULL
series	NULL
of	NULL
specific	NULL
amino	NULL
acid	NULL
substitutions	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
full-length	NULL
IxBa	NULL
protein	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
substitution	NULL
of	NULL
alanine	NULL
for	NULL
either	NULL
Ser-32	NULL
or	NULL
Ser-36	NULL
in	NULL
ectopic	NULL
IxBa	NULL
(	NULL
mutant	NULL
S32A	NULL
or	NULL
$	NULL
36A	NULL
)	NULL
markedly	NULL
attenuated	NULL
Tax-mediated	NULL
transactivation	NULL
of	NULL
HIV-kB-CAT	NULL
in	NULL
Jurkat	NULL
T-cell	NULL
transfectants	NULL
.	NULL

These	NULL
dominant-negative	NULL
effects	NULL
were	NULL
highly	NULL
selective	NULL
,	NULL
because	NULL
IxBa	NULL
constructs	NULL
containing	NULL
point	NULL
mutations	NULL
at	NULL
two	NULL
other	NULL
potential	NULL
phosphorylation	NULL
sites	NULL
in	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
IxBa	NULL
,	NULL
including	NULL
an	NULL
alanine	NULL
substitution	NULL
at	NULL
Ser-63	NULL
(	NULL
mutant	NULL
S63A	NULL
)	NULL
or	NULL
phenylalanine	NULL
for	NULL
Tyr-42	NULL
(	NULL
mutant	NULL
Y42F	NULL
)	NULL
,	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
Tax	NULL
response	NULL
.	NULL

To	NULL
extend	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
reconstitute	NULL
the	NULL
signaling	NULL
activity	NULL
of	NULL
IxBa	NULL
mutants	NULL
S32A	NULL
and	NULL
$	NULL
36A	NULL
by	NULL
replacing	NULL
alanine	NULL
with	NULL
charged	NULL
amino	NULL
acids	NULL
that	NULL
can	NULL
function	NULL
as	NULL
phosphoserine	NULL
mimetics	NULL
(	NULL
1	NULL
,	NULL
17	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
transactivate	NULL
HIV-kB-CAT	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ectopic	NULL
IxBa	NULL
was	NULL
significantly	NULL
reconstituted	NULL
in	NULL
vivo	NULL
(	NULL
>	NULL
90	NULL
%	NULL
relative	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
)	NULL
by	NULL
introducing	NULL
glutamic	NULL
acid	NULL
at	NULL
either	NULL
site	NULL
(	NULL
mutants	NULL
S32E	NULL
and	NULL
$	NULL
36E	NULL
)	NULL
.	NULL

However	NULL
,	NULL
introduction	NULL
of	NULL
alanine	NULL
at	NULL
the	NULL
adjacent	NULL
unmodified	NULL
serine	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
;	NULL
mutants	NULL
S32A/836E	NULL
and	NULL
S	NULL
$	NULL
32E/836A	NULL
)	NULL
converted	NULL
these	NULL
reconstituted	NULL
IxBa	NULL
mutants	NULL
to	NULL
a	NULL
signaling-defective	NULL
phenotype	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
function	NULL
as	NULL
independent	NULL
regulatory	NULL
sites	NULL
within	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
critical	NULL
for	NULL
Tax-mediated	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Biochemical	NULL
analyses	NULL
of	NULL
site-directed	NULL
IxBa	NULL
mutants	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
observed	NULL
dominant-negative	NULL
phenotypes	NULL
were	NULL
due	NULL
to	NULL
specific	NULL
defects	NULL
in	NULL
the	NULL
signaling	NULL
function	NULL
of	NULL
IxBa	NULL
,	NULL
we	NULL
next	NULL
performed	NULL
studies	NULL
with	NULL
extracts	NULL
from	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
select	NULL
site-directed	NULL
mutants	NULL
.	NULL

As	NULL
demonstrated	NULL
by	NULL
immunoblotting	NULL
with	NULL
RelA-specific	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
,	NULL
variants	NULL
of	NULL
IxBa	NULL
containing	NULL
either	NULL
an	NULL
alanine	NULL
or	NULL
glutamic	NULL
acid	NULL
substitution	NULL
at	NULL
Ser-32	NULL
(	NULL
mutants	NULL
S32A	NULL
and	NULL
S32E	NULL
)	NULL
retained	NULL
the	NULL
capacity	NULL
to	NULL
associate	NULL
with	NULL
endogenous	NULL
RelA	NULL
complexes	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
REGULATION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
2813	NULL
Tax	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
mutations	NULL
did	NULL
not	NULL
perturb	NULL
the	NULL
formation	NULL
of	NULL
latent	NULL
NF-	NULL
«	NULL
B/IxBa	NULL
complexes	NULL
.	NULL

However	NULL
,	NULL
in	NULL
keeping	NULL
with	NULL
their	NULL
distinct	NULL
functional	NULL
phenotypes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
only	NULL
IxBa	NULL
mutant	NULL
$	NULL
32	NULL
failed	NULL
to	NULL
permit	NULL
Tax-induced	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
$	NULL
32A	NULL
mutant	NULL
of	NULL
IxBa	NULL
is	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
a	NULL
specific	NULL
defect	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
transduce	NULL
Tax-dependent	NULL
signals	NULL
that	NULL
uncouple	NULL
NF-	NULL
«	NULL
B/IxBa	NULL
complexes	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
this	NULL
dominant-negative	NULL
phenotype	NULL
,	NULL
introduction	NULL
of	NULL
glutamic	NULL
acid	NULL
rather	NULL
than	NULL
alanine	NULL
at	NULL
Ser-32	NULL
was	NULL
sufficient	NULL
to	NULL
rescue	NULL
the	NULL
signal-transducing	NULL
function	NULL
of	NULL
IxBa	NULL
«	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
finding	NULL
that	NULL
deletion	NULL
of	NULL
IxBa	NULL
sequences	NULL
encompassing	NULL
Ser-32	NULL
rendered	NULL
IxBa	NULL
refractile	NULL
to	NULL
Tax-induced	NULL
degradation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
whether	NULL
these	NULL
two	NULL
functionally	NULL
distinct	NULL
classes	NULL
of	NULL
point	NULL
mutations	NULL
differentially	NULL
affected	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
cytoplasmic	NULL
IxBa	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
forms	NULL
of	NULL
Tax	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
S32E	NULL
mutant	NULL
of	NULL
IxBa	NULL
was	NULL
selectively	NULL
repressed	NULL
in	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
wild-type	NULL
Tax	NULL
and	NULL
Tax-M47	NULL
,	NULL
both	NULL
of	NULL
which	NULL
induce	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
pathway	NULL
.	NULL

These	NULL
results	NULL
were	NULL
fully	NULL
consistent	NULL
with	NULL
that	NULL
observed	NULL
in	NULL
cells	NULL
expressing	NULL
IxBaWT	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
replacement	NULL
of	NULL
Ser-32	NULL
with	NULL
alanine	NULL
rather	NULL
than	NULL
glutamic	NULL
acid	NULL
(	NULL
mutant	NULL
$	NULL
32A	NULL
)	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
escape	NULL
of	NULL
IxBa	NULL
from	NULL
Tax-induced	NULL
breakdown	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
thus	NULL
recapitulating	NULL
the	NULL
stability	NULL
profile	NULL
of	NULL
the	NULL
IxBaAN	NULL
mutant	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
functional	NULL
and	NULL
biochemical	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
Ser-32	NULL
and/or	NULL
Ser-36	NULL
may	NULL
influence	NULL
Tax-induced	NULL
entry	NULL
of	NULL
IxBa	NULL
into	NULL
its	NULL
degradative	NULL
pathway	NULL
.	NULL

Constitutive	NULL
repression	NULL
of	NULL
NF-B-directed	NULL
transcription	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
HTLV-1	NULL
Tax	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
active	NULL
nuclear	NULL
form	NULL
of	NULL
NF-kB	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
is	NULL
posttranslationally	NULL
induced	NULL
by	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
signaling	NULL
pathways	NULL
,	NULL
including	NULL
those	NULL
mediated	NULL
by	NULL
cell	NULL
surface	NULL
receptors	NULL
for	NULL
antigen	NULL
(	NULL
41	NULL
)	NULL
and	NULL
the	NULL
cytokine	NULL
TNF-	NULL
«	NULL
(	NULL
19	NULL
,	NULL
61	NULL
,	NULL
74	NULL
)	NULL
.	NULL

Prior	NULL
studies	NULL
with	NULL
Jurkat	NULL
T	NULL
cells	NULL
have	NULL
clearly	NULL
demonstrated	NULL
that	NULL
activation	NULL
of	NULL
these	NULL
pathways	NULL
leads	NULL
to	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
endogenous	NULL
IxBa	NULL
(	NULL
10	NULL
,	NULL
19	NULL
,	NULL
25	NULL
,	NULL
80	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
these	NULL
Tax-independent	NULL
pathways	NULL
for	NULL
NF-kB	NULL
activation	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
either	NULL
IxBaWT	NULL
or	NULL
a	NULL
mutant	NULL
lacking	NULL
the	NULL
SR	NULL
domain	NULL
and	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
TNF-	NULL
«	NULL
.	NULL

Alter-natively	NULL
,	NULL
transfectants	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
a	NULL
combination	NULL
that	NULL
simulates	NULL
the	NULL
effects	NULL
of	NULL
antigen	NULL
receptor	NULL
stimulation	NULL
on	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
and	NULL
on	NULL
release	NULL
of	NULL
ionized	NULL
calcium	NULL
from	NULL
intracellular	NULL
stores	NULL
(	NULL
24	NULL
,	NULL
50	NULL
,	NULL
88	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
both	NULL
of	NULL
these	NULL
NF-	NULL
«	NULL
B	NULL
agonists	NULL
induced	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
ectopic	NULL
IxBaWT	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
forms	NULL
of	NULL
IxBa	NULL
lacking	NULL
the	NULL
SR	NULL
domain	NULL
were	NULL
resistant	NULL
to	NULL
degradation	NULL
under	NULL
either	NULL
stimulatory	NULL
condition	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
S3ZA	NULL
mutant	NULL
of	NULL
IxBa	NULL
in	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
a	NULL
finding	NULL
that	NULL
is	NULL
fully	NULL
consistent	NULL
with	NULL
the	NULL
stabilizing	NULL
effects	NULL
of	NULL
this	NULL
point	NULL
mutation	NULL
on	NULL
IxBa	NULL
when	NULL
introduced	NULL
into	NULL
Tax-expressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

To	NULL
extend	NULL
these	NULL
biochemical	NULL
results	NULL
,	NULL
we	NULL
next	NULL
assessed	NULL
the	NULL
functional	NULL
properties	NULL
of	NULL
each	NULL
IxBa	NULL
mutant	NULL
in	NULL
T	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
HIV-kB-CAT	NULL
reporter	NULL
.	NULL

Both	NULL
TNF	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
and	NULL
PMA-ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
stimulated	NULL
<	NULL
B-directed	NULL
transcription	NULL
from	NULL
the	NULL
HIV-	NULL
«	NULL
B	NULL
enhancer	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
transfected	NULL
IKxBaWT	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
induction	NULL
of	NULL
HIV-	NULL
«	NULL
B-CAT	NULL
by	NULL
these	NULL
NF-	NULL
«	NULL
xB	NULL
agonists	NULL
was	NULL
prevented	NULL
in	NULL
T	NULL
cells	NULL
expressing	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
IxBa	NULL
that	NULL
lacked	NULL
the	NULL
Tax-responsive	NULL
SR	NULL
2814	NULL
BROCKMAN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
Anti-lkBa	NULL
Anti-RelA	NULL
tp	NULL
or	NULL
os	NULL
4	NULL
)	NULL
soe	NULL
7	NULL
8°	NULL
t	NULL
1	NULL
1	NULL
1	NULL
1	NULL
I	NULL
[	NULL
U	NULL
97	NULL
-	NULL
'	NULL
68	NULL
-	NULL
m__	NULL
_-	NULL
aes	NULL
--	NULL
46-	NULL
<	NULL
u	NULL
~~~	NULL
*I	NULL
31	NULL
-	NULL
20	NULL
-	NULL
wo	NULL
NJ	NULL
RR	NULL
yo	NULL
Ny	NULL
,	NULL
RR	NULL
'On	NULL
%	NULL
'	NULL
O	NULL
,	NULL
%	NULL
L	NULL
O	NULL
4	NULL
»	NULL
S.	NULL
®	NULL
C	NULL
4o	NULL
$	NULL
.	NULL

®	NULL
4	NULL
343	NULL
&	NULL
4	NULL
%	NULL
%	NULL
,	NULL
%	NULL
7	NULL
0	NULL
be	NULL
,	NULL
Cp	NULL
7	NULL
CC	NULL
*	NULL
#	NULL
*	NULL
3	NULL
.	NULL

B	NULL
pCMV4	NULL
WT	NULL
S32A	NULL
S32E	NULL
F1	NULL
p	NULL
1	NULL
I	NULL
3	NULL
4	NULL
1	NULL
1	NULL
5	NULL
6	NULL
1	NULL
I	NULL
7	NULL
8	NULL
1	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
cap	NULL
came	NULL
houti	NULL
,	NULL
ant	NULL
nave	NULL
aap	NULL
am	NULL
C	NULL
ssog	NULL
S32A	NULL
bor	NULL
g	NULL
400g	NULL
e	NULL
Ios	NULL
]	NULL
97	NULL
-	NULL
*	NULL
68	NULL
-	NULL
46	NULL
~	NULL
lam	NULL
--	NULL
-	NULL
-	NULL
-.__.44—|1	NULL
<	NULL
Ba	NULL
31	NULL
-	NULL
TBHP	NULL
as	NULL
rat	NULL
us	NULL
«	NULL
-	NULL
NS	NULL
20	NULL
-	NULL
kkkkkkkk	NULL
)	NULL
Co	NULL
4	NULL
4	NULL
3	NULL
to	NULL
5	NULL
3	NULL
Cy	NULL
t	NULL
,	NULL
%	NULL
tu	NULL
to	NULL
%	NULL
*	NULL
%	NULL
5	NULL
a	NULL
a	NULL
``	NULL
a	NULL
4	NULL
t	NULL
4	NULL
.	NULL

FIG	NULL
.	NULL

6	NULL
.	NULL

Biochemical	NULL
properties	NULL
of	NULL
site-directed	NULL
IxBa	NULL
mutants	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Association	NULL
with	NULL
endogenous	NULL
RelA	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
FLAG	NULL
epitope-tagged	NULL
derivatives	NULL
of	NULL
the	NULL
indicated	NULL
pCMV4-based	NULL
IxBa	NULL
expression	NULL
vectors	NULL
(	NULL
20	NULL
g	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
complexes	NULL
containing	NULL
ectopic	NULL
IxBa	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
monoclonal	NULL
anti-FLAG	NULL
antibody	NULL
,	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
a	NULL
peptide-specific	NULL
antiserum	NULL
for	NULL
cither	NULL
IxBo	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
or	NULL
RelA	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Induction	NULL
of	NULL
nuclear	NULL
NF-xB/Re	NULL
!	NULL

activity	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
pCMV4-based	NULL
expression	NULL
vectors	NULL
encoding	NULL
RelA	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
,	NULL
Tax	NULL
(	NULL
10	NULL
mg	NULL
)	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
IxBa	NULL
constructs	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
cycloheximide	NULL
(	NULL
50	NULL
ug/m	NULL
!	NULL
)	NULL

for	NULL
2	NULL
h	NULL
and	NULL
then	NULL
harvested	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
as	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
RelA	NULL
homodimers	NULL
(	NULL
upper	NULL
)	NULL
and	NULL
RelA/p30	NULL
heterodimers	NULL
(	NULL
lower	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Steady-state	NULL
levels	NULL
of	NULL
IxBa	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
indicated	NULL
epitope-tagged	NULL
mutants	NULL
of	NULL
IxBa	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
and	NULL
either	NULL
control	NULL
vector	NULL
(	NULL
pCMV4	NULL
;	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
or	NULL
the	NULL
indicated	NULL
forms	NULL
of	NULL
Tax	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
.	NULL

Mutants	NULL
of	NULL
the	NULL
wild-type	NULL
Tax	NULL
protein	NULL
(	NULL
Tax-WT	NULL
)	NULL
that	NULL
are	NULL
defective	NULL
in	NULL
either	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Tax-M22	NULL
)	NULL
or	NULL
CREB/ATF	NULL
(	NULL
Tax-M47	NULL
)	NULL
activating	NULL
function	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
77	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
after	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
monoclonal	NULL
anti-FLAG	NULL
antibody	NULL
,	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
IxBo-specific	NULL
antiserum	NULL
(	NULL
amino	NULL
acids	NULL
289	NULL
to	NULL
317	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
and	NULL
sizes	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
C.	NULL
NS	NULL
,	NULL
nonspecific	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

IkBaWT	NULL
IkBaAN	NULL
[	NULL
4	NULL
o	NULL
2	NULL
os	NULL
4	NULL
s	NULL
le	NULL
7	NULL
Os	NULL
#	NULL
s	NULL
10	NULL
]	NULL
oi	NULL
Pood	NULL
ood	NULL
oa	NULL
PMA	NULL
+	NULL
aam	NULL
-_	NULL
_-	NULL
wow-	NULL
coa	NULL
,	NULL
«	NULL
upar	NULL
cmm	NULL
IONOMYCIN	NULL
TNFG	NULL
Crem	NULL
oo	NULL
.	NULL

~	NULL
cuse	NULL
cume	NULL
caren	NULL
coun	NULL
e	NULL
0	NULL
0.50	NULL
1	NULL
2	NULL
4	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
4	NULL
TIME	NULL
(	NULL
HOURS	NULL
)	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

The	NULL
SR	NULL
domain	NULL
regulates	NULL
the	NULL
induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
encoding	NULL
FLAG	NULL
epitope-tagged	NULL
derivatives	NULL
of	NULL
either	NULL
IxBaWT	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
or	NULL
IxBaAN	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
cycloheximide	NULL
(	NULL
50	NULL
pg/ml	NULL
,	NULL
1	NULL
h	NULL
)	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
with	NULL
either	NULL
TNF-	NULL
«	NULL
(	NULL
300	NULL
U/m1	NULL
)	NULL
or	NULL
combinations	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
1	NULL
M	NULL
)	NULL
.	NULL

Tagged	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
monoclonal	NULL
anti-FLAG	NULL
antibody	NULL
,	NULL
fractioned	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
an	NULL
IxBo-specific	NULL
antiserum	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
no	NULL
significant	NULL
degradation	NULL
of	NULL
IxBa	NULL
was	NULL
observed	NULL
in	NULL
control	NULL
cells	NULL
treated	NULL
with	NULL
cycloheximide	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
agonist	NULL
.	NULL

domain	NULL
(	NULL
IxBa	NULL
«	NULL
AN	NULL
)	NULL
.	NULL

These	NULL
signal-dependent	NULL
transcriptional	NULL
responses	NULL
were	NULL
also	NULL
attenuated	NULL
in	NULL
T	NULL
cells	NULL
expressing	NULL
a	NULL
mutant	NULL
of	NULL
IxBa	NULL
containing	NULL
an	NULL
alanine	NULL
substitution	NULL
at	NULL
either	NULL
Ser-32	NULL
or	NULL
Ser-36	NULL
.	NULL

However	NULL
,	NULL
both	NULL
signal	NULL
transduction	NULL
pathways	NULL
were	NULL
significantly	NULL
reconstituted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IxBa	NULL
constructs	NULL
containing	NULL
glutamic	NULL
acid	NULL
rather	NULL
than	NULL
alanine	NULL
at	NULL
these	NULL
two	NULL
regulatory	NULL
sites	NULL
.	NULL

These	NULL
results	NULL
with	NULL
TNF-	NULL
«	NULL
-	NULL
and	NULL
PMA-ionomycin	NULL
100	NULL
so	NULL
g	NULL
so	NULL
=	NULL
.	NULL

40	NULL
}	NULL
A	NULL
3	NULL
20+	NULL
O	NULL
<	NULL
&	NULL
-	NULL
|B	NULL
O	NULL
100	NULL
4	NULL
$	NULL
F	NULL
80	NULL
©	NULL
60	NULL
CC	NULL
40	NULL
20	NULL
-	NULL
I	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Constitutive	NULL
repression	NULL
of	NULL
cytokine	NULL
and	NULL
T-cell	NULL
activation	NULL
pathways	NULL
by	NULL
dominant-negative	NULL
mutants	NULL
of	NULL
IxBa	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
HIV-	NULL
«	NULL
B-CAT	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
and	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
indicated	NULL
site-directed	NULL
mutants	NULL
of	NULL
human	NULL
IxBa	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
of	NULL
growth	NULL
,	NULL
half	NULL
of	NULL
each	NULL
culture	NULL
was	NULL
stimulated	NULL
for	NULL
20	NULL
h	NULL
with	NULL
either	NULL
TNF-	NULL
«	NULL
(	NULL
300	NULL
U/ml	NULL
!	NULL
)	NULL

(	NULL
A	NULL
)	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
1	NULL
M	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
measured	NULL
in	NULL
normalized	NULL
extracts	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
59	NULL
)	NULL
.	NULL

For	NULL
each	NULL
mutant	NULL
,	NULL
induction	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
over	NULL
basal	NULL
levels	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
induced	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
IxBaWT	NULL
cDNA	NULL
(	NULL
mean	NULL
fold	NULL
induction	NULL
=	NULL
9.4	NULL
+	NULL
0.9	NULL
for	NULL
TNF-	NULL
«	NULL
and	NULL
17.1	NULL
+	NULL
1.7	NULL
for	NULL
PMA-ionomycin	NULL
)	NULL
.	NULL

Error	NULL
bars	NULL
depict	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
percentage	NULL
value	NULL
derived	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
stimulated	NULL
T	NULL
cells	NULL
correlated	NULL
precisely	NULL
with	NULL
the	NULL
functional	NULL
phenotypes	NULL
of	NULL
all	NULL
IxBa	NULL
mutants	NULL
introduced	NULL
into	NULL
Tax-expressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
amino	NULL
terminus	NULL
of	NULL
IxBa	NULL
specifies	NULL
an	NULL
SR	NULL
domain	NULL
.	NULL

Since	NULL
its	NULL
initial	NULL
discovery	NULL
in	NULL
B	NULL
lymphocytes	NULL
(	NULL
75	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
emerged	NULL
as	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
inducible	NULL
transcriptional	NULL
machinery	NULL
that	NULL
mediates	NULL
T-cell	NULL
activation	NULL
and	NULL
growth	NULL
(	NULL
31	NULL
,	NULL
32	NULL
,	NULL
46	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
coopted	NULL
by	NULL
HIV	NULL
and	NULL
HTLV-1	NULL
to	NULL
sub-serve	NULL
distinct	NULL
retroviral	NULL
functions	NULL
in	NULL
infected	NULL
CD4*	NULL
cells	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

A	NULL
hallmark	NULL
feature	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
its	NULL
extraordinary	NULL
capacity	NULL
to	NULL
respond	NULL
to	NULL
a	NULL
diverse	NULL
range	NULL
of	NULL
physiologic	NULL
and	NULL
pathologic	NULL
cues	NULL
,	NULL
including	NULL
T-cell	NULL
receptor	NULL
ligands	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
viral	NULL
proteins	NULL
(	NULL
32	NULL
)	NULL
.	NULL

It	NULL
is	NULL
now	NULL
clear	NULL
that	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-kB	NULL
is	NULL
regulated	NULL
from	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
by	NULL
IxBa	NULL
,	NULL
which	NULL
is	NULL
rapidly	NULL
degraded	NULL
during	NULL
cellular	NULL
activation	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
25	NULL
,	NULL
35	NULL
,	NULL
80	NULL
,	NULL
81	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
unifying	NULL
explanation	NULL
for	NULL
how	NULL
disparate	NULL
viral	NULL
and	NULL
cellular	NULL
stimuli	NULL
converge	NULL
on	NULL
this	NULL
enzy-matic	NULL
checkpoint	NULL
has	NULL
remained	NULL
elusive	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
signaling	NULL
mechanism	NULL
in	NULL
detail	NULL
,	NULL
we	NULL
devised	NULL
an	NULL
approach	NULL
to	NULL
reconstitute	NULL
human	NULL
T	NULL
lymphocytes	NULL
with	NULL
ectopic	NULL
forms	NULL
of	NULL
IxBa	NULL
that	NULL
interface	NULL
with	NULL
the	NULL
endogenous	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
pathway	NULL
.	NULL

When	NULL
the	NULL
wild-type	NULL
IxBa	NULL
cDNA	NULL
was	NULL
expressed	NULL
in	NULL
this	NULL
in	NULL
vivo	NULL
system	NULL
,	NULL
the	NULL
resultant	NULL
ectopic	NULL
protein	NULL
fully	NULL
recapitulated	NULL
the	NULL
inhibitory	NULL
and	NULL
signal-transducing	NULL
functions	NULL
of	NULL
endogenous	NULL
IxBa	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
IxBa	NULL
lacking	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
36	NULL
(	NULL
IxBaAN	NULL
)	NULL
failed	NULL
to	NULL
support	NULL
NF-	NULL
«	NULL
kB-directed	NULL
transcription	NULL
from	NULL
the	NULL
HIV	NULL
enhancer	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
potent	NULL
NF-	NULL
«	NULL
B	NULL
inducers	NULL
,	NULL
including	NULL
HTLV-1	NULL
Tax	NULL
,	NULL
TNF-a	NULL
«	NULL
@	NULL
,	NULL
and	NULL
combinations	NULL
of	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
iono-phore	NULL
.	NULL

Based	NULL
on	NULL
coimmunoprecipitation	NULL
and	NULL
gel	NULL
retardation	NULL
studies	NULL
,	NULL
however	NULL
,	NULL
this	NULL
dominant-negative	NULL
form	NULL
of	NULL
IxBa	NULL
retained	NULL
both	NULL
its	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
and	NULL
inhibitory	NULL
functions	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

These	NULL
in	NULL
vivo	NULL
results	NULL
thus	NULL
define	NULL
N-terminal	NULL
regulatory	NULL
sequences	NULL
in	NULL
IxBa	NULL
that	NULL
integrate	NULL
proximal	NULL
biochemical	NULL
signals	NULL
leading	NULL
to	NULL
the	NULL
induced	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

This	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
represents	NULL
a	NULL
key	NULL
target	NULL
for	NULL
antigen-	NULL
and	NULL
cytokine	NULL
receptor-mediated	NULL
pathways	NULL
that	NULL
converge	NULL
on	NULL
the	NULL
set	NULL
of	NULL
T-cell	NULL
activation	NULL
genes	NULL
under	NULL
NF-kB	NULL
control	NULL
.	NULL

The	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
is	NULL
also	NULL
inextricably	NULL
linked	NULL
to	NULL
the	NULL
pathophysiologic	NULL
mechanism	NULL
by	NULL
which	NULL
HTLV-1	NULL
Tax	NULL
deregulates	NULL
the	NULL
function	NULL
of	NULL
NF-xB	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
aberrant	NULL
expression	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
these	NULL
growth-related	NULL
cellular	NULL
genes	NULL
.	NULL

Moreover	NULL
,	NULL
preliminary	NULL
experiments	NULL
conducted	NULL
with	NULL
stably	NULL
transfected	NULL
pre-B	NULL
cells	NULL
indicate	NULL
that	NULL
this	NULL
region	NULL
of	NULL
IxBa	NULL
is	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
in	NULL
response	NULL
to	NULL
bacterial	NULL
lipopolysaccharide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
SR	NULL
domain	NULL
collaborates	NULL
with	NULL
other	NULL
distal	NULL
regulatory	NULL
sequences	NULL
in	NULL
IxBa	NULL
in	NULL
order	NULL
to	NULL
govern	NULL
its	NULL
biologic	NULL
activity	NULL
.	NULL

For	NULL
example	NULL
,	NULL
acquisition	NULL
of	NULL
this	NULL
pleiotropic	NULL
signaling	NULL
function	NULL
may	NULL
also	NULL
involve	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
IkBa	NULL
«	NULL
(	NULL
amino	NULL
acids	NULL
243	NULL
to	NULL
317	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
PEST	NULL
sequences	NULL
characteristic	NULL
of	NULL
many	NULL
proteins	NULL
that	NULL
undergo	NULL
rapid	NULL
turnover	NULL
(	NULL
33	NULL
,	NULL
66	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
removal	NULL
of	NULL
the	NULL
entire	NULL
PEST	NULL
domain	NULL
of	NULL
IxBa	NULL
disrupts	NULL
its	NULL
RelA	NULL
binding	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
preliminary	NULL
studies	NULL
with	NULL
an	NULL
IxBa	NULL
mutant	NULL
retaining	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
PEST	NULL
domain	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
additional	NULL
determinants	NULL
in	NULL
this	NULL
C-terminal	NULL
region	NULL
that	NULL
may	NULL
act	NULL
in	NULL
concert	NULL
with	NULL
the	NULL
N-terminal	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
to	NULL
mediate	NULL
its	NULL
signal-transducing	NULL
function	NULL
.	NULL

Role	NULL
of	NULL
IxBa	NULL
in	NULL
NF-KB	NULL
induction	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Recent	NULL
studies	NULL
with	NULL
mice	NULL
transgenic	NULL
for	NULL
the	NULL
Tax	NULL
gene	NULL
suggest	NULL
that	NULL
the	NULL
constitutive	NULL
pattern	NULL
of	NULL
NF-kB	NULL
expression	NULL
in	NULL
HTLV-1-infected	NULL
REGULATION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
2815	NULL
cells	NULL
may	NULL
be	NULL
required	NULL
to	NULL
maintain	NULL
a	NULL
neoplastic	NULL
state	NULL
of	NULL
deregulated	NULL
growth	NULL
control	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Insights	NULL
into	NULL
the	NULL
precise	NULL
mechanism	NULL
underlying	NULL
this	NULL
pathogenic	NULL
virus-host	NULL
interaction	NULL
have	NULL
been	NULL
complicated	NULL
by	NULL
the	NULL
pleiotropic	NULL
effects	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
on	NULL
the	NULL
T-cell	NULL
activation	NULL
program	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
assemble	NULL
with	NULL
several	NULL
components	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
that	NULL
are	NULL
structurally	NULL
and	NULL
functionally	NULL
related	NULL
to	NULL
IxBa	NULL
.	NULL

These	NULL
Tax-interactive	NULL
components	NULL
include	NULL
the	NULL
Rel-related	NULL
precursors	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p52	NULL
NF-kB/Re	NULL
!	NULL

l	NULL
subunits	NULL
(	NULL
p105	NULL
and	NULL
p100	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
12	NULL
,	NULL
36	NULL
,	NULL
87	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
IxBy	NULL
(	NULL
37	NULL
)	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p105	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Like	NULL
IxBa	NULL
,	NULL
all	NULL
three	NULL
of	NULL
these	NULL
polypeptides	NULL
contain	NULL
multiple	NULL
ankyrin	NULL
motifs	NULL
and	NULL
inhibit	NULL
the	NULL
nuclear	NULL
expression	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
select	NULL
Rel	NULL
polypeptides	NULL
(	NULL
9	NULL
,	NULL
38	NULL
,	NULL
53	NULL
,	NULL
58	NULL
,	NULL
65	NULL
)	NULL
.	NULL

However	NULL
,	NULL
evidence	NULL
is	NULL
currently	NULL
lacking	NULL
for	NULL
either	NULL
the	NULL
presence	NULL
of	NULL
IxBy	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
or	NULL
for	NULL
Tax-induced	NULL
processing	NULL
of	NULL
p100	NULL
and	NULL
p105	NULL
to	NULL
their	NULL
functionally	NULL
active	NULL
subunits	NULL
(	NULL
42	NULL
,	NULL
82	NULL
)	NULL
.	NULL

This	NULL
study	NULL
provides	NULL
four	NULL
new	NULL
lines	NULL
of	NULL
experimental	NULL
evidence	NULL
demonstrating	NULL
that	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
couples	NULL
Tax	NULL
to	NULL
the	NULL
host	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
pathway	NULL
.	NULL

First	NULL
,	NULL
Tax	NULL
failed	NULL
to	NULL
stimulate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B-responsive	NULL
promoters	NULL
in	NULL
cells	NULL
expressing	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
IxBa	NULL
«	NULL
(	NULL
IxBaAN	NULL
)	NULL
that	NULL
lacked	NULL
this	NULL
N-terminal	NULL
regulatory	NULL
region	NULL
.	NULL

These	NULL
inhibitory	NULL
effects	NULL
were	NULL
selective	NULL
,	NULL
because	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
transactivate	NULL
promoters	NULL
that	NULL
function	NULL
independently	NULL
of	NULL
NF-kB	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
HTLV-1	NULL
LTR	NULL
)	NULL
was	NULL
unimpeded	NULL
in	NULL
cells	NULL
coexpressing	NULL
IxBoAN	NULL
.	NULL

Second	NULL
,	NULL
in	NULL
vivo	NULL
expression	NULL
of	NULL
IxBaAN	NULL
but	NULL
not	NULL
its	NULL
wild-type	NULL
counterpart	NULL
prevented	NULL
Tax-induced	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
.	NULL

Third	NULL
,	NULL
whereas	NULL
Tax	NULL
stimulated	NULL
the	NULL
turnover	NULL
of	NULL
wild-type	NULL
IxBa	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
SR	NULL
domain	NULL
rendered	NULL
this	NULL
inhibitor	NULL
completely	NULL
resistant	NULL
to	NULL
Tax-induced	NULL
degradation	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
latter	NULL
two	NULL
findings	NULL
establish	NULL
a	NULL
direct	NULL
mechanistic	NULL
link	NULL
between	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
stimulate	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
to	NULL
trigger	NULL
the	NULL
induction	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
expression	NULL
.	NULL

Fourth	NULL
,	NULL
point	NULL
mutations	NULL
in	NULL
Tax	NULL
that	NULL
ablate	NULL
its	NULL
NF-kB-inducing	NULL
function	NULL
(	NULL
77	NULL
)	NULL
also	NULL
block	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
stimulate	NULL
IxBa	NULL
breakdown	NULL
,	NULL
thus	NULL
providing	NULL
further	NULL
evidence	NULL
for	NULL
the	NULL
specificity	NULL
and	NULL
functional	NULL
relevance	NULL
of	NULL
this	NULL
virus-host	NULL
interaction	NULL
.	NULL

These	NULL
findings	NULL
extend	NULL
two	NULL
recent	NULL
studies	NULL
indicating	NULL
that	NULL
Tax	NULL
induces	NULL
the	NULL
proteolytic	NULL
breakdown	NULL
of	NULL
endogenous	NULL
IxBa	NULL
in	NULL
both	NULL
stable	NULL
transfectants	NULL
and	NULL
HTLV-l-infected	NULL
cells	NULL
(	NULL
42	NULL
,	NULL
82	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
IxBa	NULL
accumulates	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
following	NULL
treatment	NULL
with	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
proteasome	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
implicates	NULL
this	NULL
specific	NULL
degradation	NULL
pathway	NULL
in	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
inactivates	NULL
IxBa	NULL
.	NULL

Function	NULL
of	NULL
the	NULL
SR	NULL
domain	NULL
.	NULL

Prior	NULL
biochemical	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
IxBa	NULL
is	NULL
rapidly	NULL
and	NULL
transiently	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
before	NULL
entering	NULL
its	NULL
degradative	NULL
pathway	NULL
(	NULL
10	NULL
,	NULL
19	NULL
,	NULL
52	NULL
,	NULL
57	NULL
,	NULL
81	NULL
)	NULL
.	NULL

This	NULL
inducibly	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
accumulates	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
proteasome	NULL
inhibitors	NULL
that	NULL
completely	NULL
block	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
phosphorylation	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
trigger	NULL
the	NULL
dissociation	NULL
of	NULL
intact	NULL
IxBa	NULL
from	NULL
NF-kB	NULL
(	NULL
62	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
two	NULL
regulatory	NULL
serines	NULL
within	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
that	NULL
influence	NULL
its	NULL
biologic	NULL
activity	NULL
in	NULL
a	NULL
conditional	NULL
manner	NULL
.	NULL

Specifically	NULL
,	NULL
substitution	NULL
of	NULL
either	NULL
Ser-32	NULL
or	NULL
Ser-36	NULL
with	NULL
alanine	NULL
largely	NULL
disrupted	NULL
the	NULL
signal-transducing	NULL
function	NULL
of	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
either	NULL
Tax	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
or	NULL
PMA-ionomycin	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
introduction	NULL
of	NULL
a	NULL
phosphoserine	NULL
mimetic	NULL
at	NULL
these	NULL
positions	NULL
restored	NULL
the	NULL
in	NULL
vivo	NULL
signaling	NULL
activity	NULL
of	NULL
IxBa	NULL
.	NULL

Although	NULL
direct	NULL
proof	NULL
that	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
are	NULL
sites	NULL
for	NULL
either	NULL
basal	NULL
or	NULL
induced	NULL
phosphorylation	NULL
is	NULL
lacking	NULL
,	NULL
these	NULL
mutational	NULL
studies	NULL
are	NULL
consistent	NULL
with	NULL
this	NULL
possibility	NULL
.	NULL

Furthermore	NULL
,	NULL
phosphoamino	NULL
acid	NULL
analyses	NULL
indicate	NULL
that	NULL
endogenous	NULL
IxBa	NULL
is	NULL
basally	NULL
phosphorylated	NULL
primarily	NULL
on	NULL
serine	NULL
and	NULL
threo-nine	NULL
residues	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Two	NULL
findings	NULL
reported	NULL
in	NULL
this	NULL
study	NULL
indicate	NULL
that	NULL
the	NULL
SR	NULL
2816	NULL
BROCKMAN	NULL
ET	NULL
AL	NULL
.	NULL

domain	NULL
of	NULL
IxBa	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
targeting	NULL
mechanism	NULL
that	NULL
facilitates	NULL
recognition	NULL
of	NULL
IxBa	NULL
as	NULL
a	NULL
proteolytic	NULL
sub-strate	NULL
.	NULL

First	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
IxBa	NULL
mutants	NULL
lacking	NULL
this	NULL
domain	NULL
escape	NULL
from	NULL
degradation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
Tax	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
or	NULL
PMA-ionomycin	NULL
,	NULL
thereby	NULL
blocking	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
.	NULL

Second	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
SR	NULL
domain	NULL
prevented	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
labile	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
that	NULL
has	NULL
been	NULL
previously	NULL
detected	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
NF-	NULL
«	NULL
B-inducing	NULL
agents	NULL
(	NULL
10	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
52	NULL
,	NULL
57	NULL
,	NULL
81	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
SR	NULL
domain	NULL
contains	NULL
determinants	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
both	NULL
signal-dependent	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
of	NULL
IxBa	NULL
.	NULL

One	NULL
potential	NULL
explanation	NULL
for	NULL
these	NULL
findings	NULL
is	NULL
that	NULL
disruption	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
inhibitor	NULL
interferes	NULL
with	NULL
a	NULL
regulated	NULL
phosphorylation	NULL
step	NULL
(	NULL
s	NULL
)	NULL
that	NULL
serves	NULL
to	NULL
brand	NULL
IxBa	NULL
for	NULL
rapid	NULL
breakdown	NULL
.	NULL

For	NULL
example	NULL
,	NULL
our	NULL
amino	NULL
acid	NULL
replacement	NULL
studies	NULL
suggest	NULL
that	NULL
agonist-in-duced	NULL
changes	NULL
in	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
the	NULL
SR	NULL
domain	NULL
at	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
may	NULL
influence	NULL
the	NULL
proteolytic	NULL
stability	NULL
of	NULL
IxBa	NULL
.	NULL

However	NULL
,	NULL
in	NULL
light	NULL
of	NULL
emerging	NULL
evidence	NULL
for	NULL
involvement	NULL
of	NULL
the	NULL
proteasome	NULL
in	NULL
this	NULL
process	NULL
(	NULL
62	NULL
)	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
functions	NULL
in	NULL
the	NULL
acquisition	NULL
of	NULL
other	NULL
distinct	NULL
degradation	NULL
signals	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
.	NULL

Conclusions	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
studies	NULL
reveal	NULL
an	NULL
SR	NULL
domain	NULL
within	NULL
IxBa	NULL
that	NULL
is	NULL
coupled	NULL
to	NULL
both	NULL
viral	NULL
and	NULL
immune	NULL
activation	NULL
pathways	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
.	NULL

Our	NULL
findings	NULL
support	NULL
a	NULL
phosphorylation-dependent	NULL
mechanism	NULL
for	NULL
functional	NULL
release	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
IxBa	NULL
control	NULL
involving	NULL
determinants	NULL
within	NULL
the	NULL
SR	NULL
domain	NULL
that	NULL
direct	NULL
the	NULL
induced	NULL
entry	NULL
of	NULL
IxBa	NULL
into	NULL
its	NULL
degradative	NULL
pathway	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
site-directed	NULL
mutations	NULL
at	NULL
two	NULL
regulatory	NULL
serines	NULL
that	NULL
are	NULL
positioned	NULL
within	NULL
the	NULL
SR	NULL
domain	NULL
of	NULL
IxBa	NULL
(	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
)	NULL
produce	NULL
constitutive	NULL
repressors	NULL
of	NULL
NF-kB-directed	NULL
transcription	NULL
with	NULL
potent	NULL
activity	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Such	NULL
constitutive	NULL
repressors	NULL
,	NULL
in	NULL
combination	NULL
with	NULL
an	NULL
appropriate	NULL
delivery	NULL
system	NULL
,	NULL
could	NULL
prove	NULL
applicable	NULL
to	NULL
the	NULL
design	NULL
of	NULL
novel	NULL
immunosuppressive	NULL
and	NULL
anti-inflammatory	NULL
drugs	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Tom	NULL
Maniatis	NULL
,	NULL
David	NULL
Kranz	NULL
,	NULL
Earl	NULL
Ruley	NULL
,	NULL
Jacek	NULL
Hawiger	NULL
,	NULL
and	NULL
John	NULL
Exton	NULL
for	NULL
critical	NULL
comments	NULL
;	NULL
Craig	NULL
Rosen	NULL
,	NULL
Warner	NULL
Greene	NULL
,	NULL
and	NULL
Albert	NULL
Baldwin	NULL
for	NULL
cDNA	NULL
clones	NULL
;	NULL
and	NULL
Emily	NULL
Vance	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
supported	NULL
by	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
grant	NULL
RO1	NULL
AI33839	NULL
from	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
to	NULL
D.W.B	NULL
.	NULL

ADDENDUM	NULL
IN	NULL
PROOF	NULL
We	NULL
have	NULL
recently	NULL
assembled	NULL
evidence	NULL
that	NULL
simultaneous	NULL
replacement	NULL
of	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
with	NULL
alanine	NULL
prevents	NULL
hyper-phosphorylation	NULL
of	NULL
IxBa	NULL
in	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
PMA-ionomy-cin	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
further	NULL
support	NULL
for	NULL
the	NULL
proposed	NULL
functional	NULL
role	NULL
of	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
in	NULL
signal-dependent	NULL
phosphorylation	NULL
events	NULL
that	NULL
render	NULL
IxBa	NULL
susceptible	NULL
to	NULL
targeted	NULL
degradation	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alessi	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Y.	NULL
Saito	NULL
,	NULL
D.	NULL
G.	NULL
Campbell	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
G.	NULL
Sithanandam	NULL
,	NULL
U.	NULL
Rapp	NULL
,	NULL
A.	NULL
Ashworth	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
and	NULL
S.	NULL
Cowley	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
sites	NULL
in	NULL
MAP	NULL
kinase	NULL
kinase-1	NULL
phosphorylated	NULL
by	NULL
p74raf-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:1610-1619	NULL
.	NULL

2	NULL
.	NULL

Andersson	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
L.	NULL
Davis	NULL
,	NULL
H.	NULL
Dahlback	NULL
,	NULL
H.	NULL
Jornvall	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Russell	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
,	NULL
structure	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
mitochondrial	NULL
cytochrome	NULL
P-450	NULL
sterol	NULL
26-hydroxylase	NULL
,	NULL
a	NULL
bile	NULL
acid	NULL
biosynthetic	NULL
enzyme	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:8222-8229	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
«	NULL
B	NULL
clement	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1655.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-Rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1875-1879.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
P.	NULL
Sista	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Molitor	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
M.	NULL
Hannink	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
v-rel	NULL
oncogene	NULL
encodes	NULL
a	NULL
kB	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

Cell	NULL
63:803-814.	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

The	NULL
IxB	NULL
proteins	NULL
:	NULL
multifunctional	NULL
regulators	NULL
of	NULL
Rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2064-2070	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasm	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913	NULL
.	NULL

Béraud	NULL
,	NULL
C.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
tax	NULL
associates	NULL
with	NULL
and	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
the	NULL
NF-xB2	NULL
p100	NULL
gene	NULL
product	NULL
:	NULL
implications	NULL
for	NULL
viral	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1374-1382	NULL
.	NULL

Blanar	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
cloning	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
helix-loop-helix	NULL
zipper	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
c-fos	NULL
.	NULL

Science	NULL
256:1014-1018	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
M.	NULL
Sickevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
same	NULL
inducible	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
regulates	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
interleukin-2	NULL
receptor-alpha	NULL
gene	NULL
and	NULL
type	NULL
I	NULL
HIV	NULL
.	NULL

Cell	NULL
53:827-836	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Sickevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
L.	NULL
Rimsky	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
J.	NULL
Hoffman	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Stimulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
I	NULL
enhancer	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
fax	NULL
gene	NULL
product	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
inducible	NULL
cellular	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1578-1586	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
xB	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
re	NULL
?	NULL

oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80	NULL
.	NULL

Boyle	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
van	NULL
der	NULL
Geer	NULL
,	NULL
and	NULL
T.	NULL
Hunter	NULL
.	NULL

1991	NULL
.	NULL

Phosphopeptide	NULL
mapping	NULL
and	NULL
phosphoamino	NULL
acid	NULL
analysis	NULL
by	NULL
two-dimensional	NULL
separation	NULL
on	NULL
thin-layer	NULL
cellulose	NULL
plates	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

201:110-149	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-254	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxBe	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
R.	NULL
Donald	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1993	NULL
.	NULL

Lipopolysaccharide	NULL
induces	NULL
phosphorylation	NULL
of	NULL
MAD3	NULL
and	NULL
activation	NULL
of	NULL
c-Rel	NULL
and	NULL
related	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
in	NULL
human	NULL
monocytic	NULL
THP-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
11803-11810	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
chain	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
nonfunctional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
.	NULL

Cell	NULL
49:47-56	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
D.	NULL
L.	NULL
Simmons	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Rel-associated	NULL
pp40	NULL
:	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Science	NULL
253:1268-1271.	NULL
deMartin	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Vanhove	NULL
,	NULL
Q.	NULL
Cheng	NULL
,	NULL
E.	NULL
Hofer	NULL
,	NULL
V.	NULL
Csizmadia	NULL
,	NULL
H.	NULL
Winkler	NULL
,	NULL
and	NULL
F.	NULL
H.	NULL
Bach	NULL
.	NULL

1993	NULL
.	NULL

Cytokine-inducible	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
of	NULL
an	NULL
IxBa-like	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2773-2779	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
M.	NULL
R.	NULL
Bush	NULL
,	NULL
J.	NULL
G.	NULL
Morgan	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
275	NULL
basepair	NULL
fragment	NULL
at	NULL
the	NULL
5°	NULL
end	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
enhances	NULL
expression	NULL
from	NULL
a	NULL
heterologous	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:395-407.	NULL
.	NULL

Frantz	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
C.	NULL
Nordby	NULL
,	NULL
G.	NULL
Bren	NULL
,	NULL
N.	NULL
Steffan	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
M.	NULL
J.	NULL
Tocci	NULL
,	NULL
S.	NULL
J.	NULL
O'Keefe	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
O'Neill	NULL
.	NULL

1994	NULL
.	NULL

Calcineurin	NULL
acts	NULL
in	NULL
synergy	NULL
with	NULL
PMA	NULL
to	NULL
inactivate	NULL
IxB/MAD3	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:861-870	NULL
.	NULL

Fujii	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Tsuchiya	NULL
,	NULL
T.	NULL
Chubjo	NULL
,	NULL
T.	NULL
Akizawa	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
with	NULL
p67°	NULL
``	NULL
``	NULL
causes	NULL
the	NULL
aberrant	NULL
induction	NULL
of	NULL
cellular	NULL
immediate	NULL
early	NULL
genes	NULL
through	NULL
CArG	NULL
boxes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2066-2076	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1992	NULL
.	NULL

IxB/MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
requires	NULL
the	NULL
transactivation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-kB	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3:1339-1352	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-kB	NULL
:	NULL
homology	NULL
to	NULL
ref	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
R.	NULL
N.	NULL
Wilson	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weinberg	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
protein-binding	NULL
sites	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
regulate	NULL
c-fos	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

64305-4316	NULL
.	NULL

Green	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
features	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
,	NULL
p.	NULL
277-311	NULL
.	NULL

In	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Levy	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
The	NULL
Retroviridae	NULL
,	NULL
vol	NULL
.	NULL

3	NULL
.	NULL

Plenum	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1989	NULL
.	NULL

HIV-1	NULL
,	NULL
HTLV-1	NULL
and	NULL
normal	NULL
T-cell	NULL
growth	NULL
:	NULL
transcriptional	NULL
strategies	NULL
and	NULL
surprises	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10:272-277	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
Rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1-62	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Hatada	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Naumann	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1993	NULL
.	NULL

Common	NULL
structural	NULL
constituents	NULL
confer	NULL
IxB	NULL
activity	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p105	NULL
and	NULL
IxB/MAD-3	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2781-2788	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben-Neriab	NULL
,	NULL
and	NULL
P.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxB-	NULL
«	NULL
is	NULL
necessary	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
K.	NULL
Ueda	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
activator	NULL
Tax	NULL
of	NULL
HTLV-I	NULL
binds	NULL
to	NULL
the	NULL
NF-xB	NULL
precursor	NULL
p105	NULL
.	NULL

Oncogene	NULL
7:1737-1742	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
binds	NULL
to	NULL
the	NULL
ankyrin	NULL
motifs	NULL
of	NULL
inhibitory	NULL
factor	NULL
xB	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF	NULL
«	NULL
B	NULL
proteins	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3584-3588	NULL
.	NULL

Inoue	NULL
,	NULL
J.-L	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
A.	NULL
Kakizuka	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1992	NULL
.	NULL

IxBy	NULL
,	NULL
a	NULL
70	NULL
kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110	NULL
NF-xB	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
.	NULL

Cell	NULL
68:1109-1120	NULL
.	NULL

Inoue	NULL
,	NULL
J.-L	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
D.	NULL
Rashid	NULL
,	NULL
N.	NULL
Bose	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1992	NULL
.	NULL

Direct	NULL
association	NULL
of	NULL
pp40/IxBB	NULL
with	NULL
rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
:	NULL
role	NULL
of	NULL
ankyrin	NULL
repeats	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:4333-4337	NULL
.	NULL

Inoue	NULL
,	NULL
J.-L.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Tsuru	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
p40	NULL
``	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
EMBO	NULL
J	NULL
.	NULL

5:2883-2888	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
A.	NULL
Chen-Tran	NULL
,	NULL
M.	NULL
Grilli	NULL
,	NULL
and	NULL
M.	NULL
Leonardo	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformed	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
256	NULL
:	NULL
1452-1456	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

Kinetic	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6443-6451	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identified	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kimata	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1991	NULL
.	NULL

Temporal	NULL
regulation	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
gene	NULL
expression	NULL
during	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I-mediated	NULL
lymphocyte	NULL
immortalization	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3134-3141	NULL
.	NULL

Kitajima	NULL
,	NULL
I.	NULL
,	NULL
T.	NULL
Shinohara	NULL
,	NULL
J.	NULL
Bilakovics	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
X.	NULL
Xu	NULL
,	NULL
and	NULL
M.	NULL
Nerenberg	NULL
.	NULL

1992	NULL
.	NULL

Ablation	NULL
of	NULL
transplanted	NULL
HTLV-1	NULL
Tax-transformed	NULL
tumors	NULL
in	NULL
mice	NULL
by	NULL
antisense	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
258:1792-1795	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-kB-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333	NULL
:	NULL
776-778	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
«	NULL
B-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
alpha-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2331-2335	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
subunit	NULL
(	NULL
Tac	NULL
or	NULL
CD25	NULL
antigen	NULL
)	NULL
gene	NULL
expression	NULL
:	NULL
binding	NULL
of	NULL
inducible	NULL
nuclear	NULL
proteins	NULL
to	NULL
discrete	NULL
promoter	NULL
sequences	NULL
correlates	NULL
with	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:4468-4472	NULL
.	NULL

Manger	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
C.	NULL
Weyand	NULL
,	NULL
J.	NULL
Goronzy	NULL
,	NULL
and	NULL
J.	NULL
Stobo	NULL
.	NULL

1985	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
:	NULL
differences	NULL
in	NULL
the	NULL
signals	NULL
required	NULL
for	NULL
IL-2	NULL
production	NULL
by	NULL
non-activated	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

135:3669-3673	NULL
.	NULL

Maruyama	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
M.	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
J.-I	NULL
.	NULL

Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-L-encoded	NULL
p40®	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
48:343-350	NULL
.	NULL

Mellits	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
S.	NULL
Goodbourn	NULL
.	NULL

1993	NULL
.	NULL

Proteolytic	NULL
degradation	NULL
of	NULL
MAD3	NULL
(	NULL
IxBa	NULL
)	NULL
and	NULL
enhanced	NULL
processing	NULL
of	NULL
the	NULL
NF-xB	NULL
precursor	NULL
p105	NULL
are	NULL
obligatory	NULL
steps	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5059-5066	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

REGULATION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
2817	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DiDonato	NULL
,	NULL
C.	NULL
Rosette	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1993.	NULL
p105	NULL
and	NULL
p98	NULL
precursor	NULL
proteins	NULL
play	NULL
an	NULL
active	NULL
role	NULL
in	NULL
NF-	NULL
«	NULL
B-mediated	NULL
signal	NULL
transduc-tion	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:705-718	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
N.	NULL
Hatada	NULL
,	NULL
H.-P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Roth-lisberger	NULL
,	NULL
H.-W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
xB	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Nakamaye	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
F.	NULL
Eckstein	NULL
.	NULL

1986	NULL
.	NULL

Inhibition	NULL
of	NULL
restriction	NULL
endonuclease	NULL
Nei	NULL
I	NULL
cleavage	NULL
by	NULL
phosphothioate	NULL
groups	NULL
and	NULL
its	NULL
application	NULL
to	NULL
oligonucle-otide-directed	NULL
mutagenesis	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:9679-9698	NULL
.	NULL

Naumann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
NF-kB	NULL
in	NULL
vivo	NULL
is	NULL
regulated	NULL
by	NULL
multiple	NULL
phosphorylations	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4597-4607	NULL
.	NULL

Naumann	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
G.	NULL
Wulczyn	NULL
,	NULL
and	NULL
C.	NULL
Sheidereit	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
and	NULL
the	NULL
proto-oncogene	NULL
product	NULL
Bel-3	NULL
are	NULL
IxB	NULL
molecules	NULL
and	NULL
control	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:213-222	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Morency	NULL
,	NULL
and	NULL
K.	NULL
Russian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

BioTechniques	NULL
5:444-447	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-C	NULL
.	NULL

Lion	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor-kappa	NULL
B.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
:	NULL
2336-2340	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
O.	NULL
J.	NULL
Rando	NULL
,	NULL
A.	NULL
L.	NULL
Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

Ubiquitin	NULL
and	NULL
the	NULL
proteasome	NULL
are	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Cell	NULL
78:773-785	NULL
.	NULL

Pearson	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Kemp	NULL
.	NULL

1991	NULL
.	NULL

Protein	NULL
kinase	NULL
phosphorylation	NULL
site	NULL
sequences	NULL
and	NULL
consensus	NULL
specificity	NULL
motifs	NULL
:	NULL
tabulations	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

200:62-81	NULL
.	NULL

Prickett	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
D.	NULL
C.	NULL
Amberg	NULL
,	NULL
and	NULL
T.	NULL
P.	NULL
Hopp	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
calcium-dependent	NULL
antibody	NULL
for	NULL
identification	NULL
and	NULL
purification	NULL
of	NULL
recombinant	NULL
proteins	NULL
.	NULL

BioTechniques	NULL
7:580-589	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71:243-253	NULL
.	NULL

Rogers	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Wells	NULL
,	NULL
and	NULL
M.	NULL
Rechsteiner	NULL
.	NULL

1986	NULL
.	NULL

Amino	NULL
acid	NULL
sequences	NULL
common	NULL
to	NULL
rapidly	NULL
degraded	NULL
proteins	NULL
:	NULL
the	NULL
PEST	NULL
hypothesis	NULL
.	NULL

Science	NULL
234	NULL
:	NULL
364-368	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
ref-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
p65-kD	NULL
subunit	NULL
of	NULL
NF-B	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
R.	NULL
Narayanan	NULL
,	NULL
J.	NULL
Klement	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
sliced	NULL
derivative	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:444-454	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
H.	NULL
Poteat	NULL
,	NULL
T.	NULL
H.	NULL
Tan	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
W.	NULL
Haseltine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1988	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-1	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89-92	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805-3817	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
Grassman	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1992	NULL
.	NULL

Antioxidants	NULL
selectively	NULL
suppress	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6288-6293	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rieber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:2247-2258	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Schiitze	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Potthoff	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
D.	NULL
Berkovic	NULL
,	NULL
K.	NULL
Wiegmann	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1992	NULL
.	NULL

TNF	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphatidylcholine-specific	NULL
phos-pholipase	NULL
C-induced	NULL
``	NULL
acidic	NULL
``	NULL
sphingomyelin	NULL
breakdown	NULL
.	NULL

Cell	NULL
71:765-776	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46:705-716	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
N.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
Tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
transactivator	NULL
(	NULL
tat	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:5389-5393	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
HTLV-1	NULL
fax	NULL
frans-activator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

41875-1885	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
W.	NULL
C.	NULL
Gob	NULL
,	NULL
and	NULL
W.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
transcriptional	NULL
activator	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
x-lor	NULL
region	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228:1430-1434	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
Rahmsdorf	NULL
,	NULL
A.	NULL
Steffen	NULL
,	NULL
M.	NULL
Litfin	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1989	NULL
.	NULL

UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
UV-induced	NULL
expression	NULL
of	NULL
2818	NULL
80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

BROCKMAN	NULL
ET	NULL
AL	NULL
.	NULL

human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
metallothio-nein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

95169-5181	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-kB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxBa	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregula-tory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
the	NULL
NF-xB	NULL
transactivator	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
by	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
containing	NULL
ankyrin	NULL
motifs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:1346-1350	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
involves	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxB	NULL
«	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
c-re/	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
L	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
transactivator	NULL
tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
interacts	NULL
with	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
and	NULL
CRE	NULL
modulator	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
21-base-pair	NULL
enhancer	NULL
of	NULL
HTLV-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:610-614	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
N.	NULL
Israel	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
M.	NULL
G.	NULL
Mattei	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
indicates	NULL
that	NULL
it	NULL
participates	NULL
in	NULL
its	NULL
own	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:195-203	NULL
.	NULL

Tewari	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
K.	NULL
L.	NULL
Mohn	NULL
,	NULL
D.	NULL
E.	NULL
Cressman	NULL
,	NULL
J.	NULL
C.	NULL
Hsu	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
R.	NULL
Taub	NULL
.	NULL

1992	NULL
.	NULL

Rapid	NULL
induction	NULL
in	NULL
regenerating	NULL
liver	NULL
of	NULL
RL/IF-1	NULL
(	NULL
an	NULL
IxB	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
RelB-p50	NULL
,	NULL
and	NULL
c-Rel-p50	NULL
)	NULL
and	NULL
PHF	NULL
,	NULL
a	NULL
novel	NULL
«	NULL
B	NULL
site	NULL
binding	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:2898-2908	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
Baeuerle	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-kB	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IxB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1975-1984	NULL
.	NULL

Watanabe	NULL
,	NULL
M.	NULL
,	NULL
M.-A	NULL
.	NULL

Muramatsu	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
K.-L.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1993	NULL
.	NULL

HTLV-I	NULL
encoded	NULL
Tax	NULL
in	NULL
association	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
enhances	NULL
nuclear	NULL
localization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

Oncogene	NULL
8:2949-2958	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Littman	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
.	NULL

Cell	NULL
76:263-274	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
Z.	NULL
Giam	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
enhances	NULL
CREB	NULL
binding	NULL
to	NULL
HTLV-I	NULL
21-base-pair	NULL
repeats	NULL
by	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7070-7074	NULL
.	NULL

